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Abstract	
  

HIV/AIDS rates among Asian and Pacific Islanders (APIs) have increased steadily in
recent years. The Health Resources and Services Administration reported in 2011 that
people living with HIV/AIDS experience psychiatric disorders at a rate 4 to 8 times
higher than the general population, with as many as 60% experiencing depression.
Studies show that short-term psychotherapy reduces depression and anxiety in people
with HIV/AIDS, and studies have indicated that patients have better health outcomes
when they receive psychotherapy in conjunction with medical treatment. It is not known
how social support relates to psychotherapy attendance or health outcomes as measured
by CD4 and viral load among people who are APIs and have HIV/AIDS. APIs comprise
a group that does not readily engage with mental health services, thus warranting focused
research attention. The purpose of this quantitative, causal, comparative study was (a) to
examine the psychotherapy attendance rates of APIs and non-APIs who have HIV/AIDS,
and (b) to identify the impact of social support on attendance rates and health outcomes
such as CD4 and viral load. The data collected from anonymous medical files at a
community health center, 993 number of records reviewed, analyzing the data using
descriptive and inferential statistics in order to identify factors that increase
psychotherapy attendance rates of people who are APIs and have HIV/AIDS. The study
findings demonstrated that non-APIs have higher psychotherapy attendance rates over
time compared to APIs, regardless of social support from case workers for attending.
Positive social change for this group indicates further examination of the meaning and
outcomes for API under these circumstances, with recommendation for use of qualitative
data gathering the perspectives of API themselves.	
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Chapter 1: Introduction
Introduction
The Centers for Disease Control and Prevention (CDC, 2012) has reported a
steady increase in cases of HIV/AIDS in recent years among Asians and Pacific Islanders
(APIs) living in the United States, indicating an increased need for medical and mental
health services for this group. This population includes people from Japan, China,
Taiwan, Southeast Asia, the Indian subcontinent, the Philippines, and other Pacific island
nations. Specific cultural factors mitigate against APIs seeking and remaining in medical
treatment and psychotherapy due to stigmas in Asian countries regarding HIV/AIDS
(Kang, Rapkin, & DeAlmeida, 2006; Sue, Cheng, Saad, & Chu, 2012), as well as stigmas
regarding mental disorders, and seeking help outside the API community. The result is
that APIs seek mental health care less often than the general population (Leong, Kim, &
Gupta, 2011), and also have a higher dropout rate from mental health care (Lin, 1994)
than the general population. There is currently little data on the initial attendance in
psychotherapy of people who are APIs and who have HIV/AIDS, or on their dropout
rates (Kang et al., 2006; Sue et al., 2012) because previous researchers have targeted nonAPI populations. In this study, I worked to understand the factors that lead people who
are APIs and who have HIV/AIDS to seek and remain in psychotherapy and whether
APIs who do so have better health outcomes.
In Chapter 1, I provide a background of the study. This chapter includes the
problem statement and justification for the need to conduct the study. I also provide a
discussion of the purpose and significance of the study as well as the research
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methodology. Further, I present a discussion of the assumptions, limitations,
delimitations, and terminologies used in the study. The chapter ends with a transition to
Chapter 2 that includes a summary and a discussion of the organization of the remainder
of the study.
Background
A limited selection of literature includes information on the attitudes of API
cultures toward HIV/AIDS and psychotherapy (Hall, Hong, Zane, & Meyer, 2011; Kang
et al., 2006; Leong et al., 2011; Miller, Yang, Hui, Choi, & Lim, 2011), and there has
been minimal scholarly discussion of the relationship between social support and
treatment adherence (including psychotherapy attendance) among APIs. Hall et al. (2011)
emphasized the dependence of Asian individuals on their families, friends, and
communities for resolving issues. Hall et al. (2011) reported that unlike EuropeanAmerican cultures, Asian cultures do not encourage direct communication with those
outside the community. Kang et al. (2006) described the close communication within the
API community, but showed that there is pressure on Asians with HIV/AIDS to not
disclose their illness and to not seek medical or psychological treatment. These authors
found that APIs who have been diagnosed with HIV/AIDS often suffer with depression
and other psychological consequences, especially because they keep the consequences
and complications of HIV/AIDS to themselves.
Asians are highly concerned with how they are perceived within and outside the
community (Leong et al., 2011). Leong et al. (2011) and Miller et al. (2011) explored
how acculturation impacts receptivity toward psychotherapy, finding that it has minimal
	
  

3	
  

impact on Asian college students. In addition, these researchers showed that the cultural
fear of loss of face has a significant impact on attitudes toward seeking mental health
care. In most cases, patients refuse to seek mental health care because of the negative
perceptions of mental conditions. Moreover, patients often deny the existence of the
mental condition and the need to seek treatment. Irvine et al. (2015) investigated the
relationship between social support and the willingness of HIV/AIDS patients in the
general population to comply with medical treatment. According to Irvine et al., social
support is one of the key factors that encourage HIV/AIDS patients to seek and complete
medical treatments. Mutchler et al. (2011), O’Laughlin, Wyatt, Kaaya, Bangsberg, and
Ware (2012), and Westmaas, Bontemos, and Bauer (2010) concluded that social support,
including that from family, friends, and case workers, helped increase treatment
adherence and promote positive health behaviors among the general population with
medical conditions other than HIV/AIDS.
Yeun, Baek, and Kim (2013) examined social cognitive theory (SCT) and health
promotion behavior in API patients who were not diagnosed with HIV/AIDS. In sum,
researchers have confirmed the links among (a) social support, (b) receptivity to mental
health care and psychotherapy attendance, and (c) health outcomes as measured by CD4
and viral load. Moreover, these researchers have reported that specific characteristics of
Asian cultures result in distinct attitudes and behaviors toward HIV/AIDS and to the idea
of seeking and remaining in mental health care, and that those attitudes and behaviors
differ from attitudes and behaviors in non-Asian cultures. Those findings show the need
for specific attention to people who are APIs and who have HIV/AIDS.
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Problem Statement
According to the Health Resources and Services Administration (2009), people
living with HIV/AIDS experience some type of psychiatric disorder at a rate four to eight
times higher than the general population, including as many as 60% who experience
depression. Scholars have suggested that short-term psychotherapy (24 sessions or fewer)
reduces depression and anxiety in HIV/AIDS patients (Himelhoch, Medoff, & Oyeniyi,
2007; Pobuda, Crothers, Goldblum, Dilley, & Koopman, 2008). Because psychiatric
disorders are often a barrier to medical treatment adherence, scholars have indicated that
HIV/AIDS patients who receive psychotherapy have better health outcomes. Positive
health outcomes are measured through CD4 and viral load, and lead to a decrease in
depression.
Social support is one of the factors that researchers have identified as leading
people to seek and remain in psychotherapy (Irvine et al., 2015; Yeun et al., 2013).
Moreover, social support generally promotes positive health outcomes, including higher
treatment adherence rates (Irvine et al., 2015; Mutchler et al., 2011; O’Laughlin et al.,
2012; Westmaas et al., 2010). It is therefore possible to draw a link between HIV/AIDS
patients with social support and psychotherapy attendance to better medical outcomes. It
is not known how social support relates to psychotherapy attendance or health outcomes
as measured through CD4 and viral load among people in the United States who are APIs
and who have HIV/AIDS.
Previous researchers have targeted non-API populations (Irvine et al., 2015) and
some have touched upon API and psychotherapy (Kang et al., 2006; Sue et al., 2012), but
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there is a lack of research on people who are APIs and who have HIV/AIDS. It is
imperative to focus on the API population due to that group’s potential cultural needs for
an expanded approach for inclusion of social support in accessing assistance with mental
health maintenance through their illness (Irvine et al., 2015). Therefore, in this study, I
sought to expand existing studies on social support, psychotherapy, and HIV/AIDS
patients to focus on the cultural background of APIs living in the United States.
Purpose of the Study
The purpose of this quantitative causal comparative study was to examine the
psychotherapy attendance rates among APIs and non-APIs who have HIV/AIDS and
psychotherapy attendance rates among APIs and non-APIs who have not been diagnosed
with HIV/AIDS in order to identify the impact of social support on attendance rates and
health outcomes such as CD4 and viral load. I employed a quantitative causal
comparative study to identify relationships between identified variables. The independent
variables were the population group membership of participants: (a) API patients who
have HIV/AIDS, (b) APIs who have not been diagnosed with HIV/AIDS, (c) non-API
patients who have HIV/AIDS, and (d) non-APIs who have not been diagnosed with
HIV/AIDS. The dependent variables were the psychotherapy attendance rates and health
outcomes such as CD4 and viral load. I collected the data from anonymous medical files
of patients with HIV/AIDS at a community health center in New York City. I analyzed
the data gathered in this study using descriptive and inferential statistics in order to
identify factors that increase psychotherapy attendance of people who are APIs and have
HIV/AIDS.
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Research Question(s) and Hypotheses
I developed the following research questions (RQs) and hypotheses for this study:
RQ1: What are the differences in psychotherapy attendance rates over a one-year
period among the following groups: (a) APIs who have HIV/AIDS patients; (b) APIs not
diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d) non-APIs not
diagnosed with HIV/AIDS?
H01a: Patients not diagnosed with HIV/AIDS have lower psychotherapy
attendance rates over time compared to patients diagnosed with HIV/AIDS.
H11a: Patients diagnosed with HIV/AIDS have higher psychotherapy attendance
rates over time compared to patients not diagnosed with HIV/AIDS.
H01b: APIs have lower psychotherapy attendance rates over time compared to
non-APIs.
H11b: Non-APIs have higher psychotherapy attendance rates over time compared
to APIs.
RQ2: What is the effect of social support (as measured by level of support given
by case workers) on retention in psychotherapy in the following groups: (a) APIs who
have HIV/AIDS; (b) APIs not diagnosed with HIV/AIDS; (c) non-APIs who have
HIV/AIDS; and (d) non-APIs not diagnosed with HIV/AIDS?
H02 a: Social support, as measured by level of support given by case workers, has
no positive impact on retention in psychotherapy.
H12 a: Social support, as measured by level of support given by case workers, has
a positive impact on retention in psychotherapy.
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RQ3: What are the differences in health outcomes, as measured through CD4 and
viral load, in the following groups: (a) people who are APIs and who have HIV/AIDS;
(b) APIs who have not been diagnosed with HIV/AIDS; (c) non-APIs who have
HIV/AIDS; and (d) non-APIs who have not been diagnosed with HIV/AIDS?
H03a: Patients not diagnosed with HIV/AIDS have lower health outcomes, as
measured through CD4 and viral load, compared to patients diagnosed with HIV/AIDS.
H13a: Patients diagnosed with HIV/AIDS have higher health outcomes, measured
through CD4 and viral load, as compared to patients not diagnosed with HIV/AIDS.
H03b: APIs have lower health outcomes, as measured through CD4 and viral load,
compared to non-APIs.
H13b: APIs have higher health outcomes, as measured through CD4 and viral
load, compared to non-APIs.
Theoretical Framework
Bandura’s (1989) social cognitive theory (SCT) provided a theoretical framework
for this study of social support and its effects on treatment adherence and health
outcomes. SCT focuses on how an individual’s knowledge and experiences, which come
from personal and environmental influences such as family and media, influence
behavior (Yeun et al., 2013). One method for increasing initial psychotherapy attendance
and decreasing dropout rates among people who are APIs and who have HIV/AIDS may
be found in the social support component of Bandura’s SCT. Individuals as well as
groups continually strive to seek closeness with other individuals or groups to feel secure
(Tasca, 2014; Yeun et al., 2013). Social support also has a significant impact on self	
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efficacy, or a person’s belief in his or her ability to succeed in certain situations. Selfefficacy is one of the key elements of SCT that motivates people to change their behavior
(Longo, Lent, & Brown, 1992; Wood & Bandura, 1989). People who believe that
behavior changes are possible have a better chance of making and maintaining changes
(Longo et al., 1992).
Researchers have shown that social support can also lead to specific concrete
behavioral changes -- including seeking and remaining in treatment -- especially for
individuals with chronic disease (Longo et al., 1992; Shen, Edwards, Courtney,
McDowell, & Wu, 2012). There is sufficient data to confirm that HIV/AIDS patients who
have strong social and emotional support and bonds with other individuals and groups
have significantly higher medical treatment adherence (Irvine et al., 2015; Li, Kuo,
Hwang, & Hsu, 2012; Stubbs, Micek, Pfeiffer, Montoya, & Gloyd, 2009; Ushie &
Jegede, 2012). It is possible that increased self-efficacy, impacted by this social support,
is also a factor in treatment adherence.
Nature of the Study
In this quantitative study, I focused on how social support influences attendance
rates in psychotherapy and consequently influences health outcomes among APIs who
have HIV/AIDS in comparison with other groups. I used a non-experimental causal
comparative research design to investigate whether relationships exist between the
identified independent and dependent variables. The data collected for this study included
patient demographics, diagnoses, adherence to medical and psychotherapy appointments,
and information about access to social support contained in anonymous medical files of
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patients with HIV/AIDS at a New York community health center. Demographic
information included patients’ age, household income, gender, sexual orientation, and
race. For RQ1, the dependent variable (DV) was psychotherapy attendance rate, and the
independent variables (IV) were race and HIV/AIDS status. For RQ2, the DV was
psychotherapy attendance rate, and the IVs were social support, race, and HIV/AIDS
status. For RQ3, the DV was health outcomes as measured by CD4 and viral load, while
the IVs were the different group memberships. I used descriptive statistics and inferential
statistics to analyze the data. I calculated frequencies and percentages to describe the
participants in the study. To answer the research questions, I performed factorial
ANOVA, repeated-measures ANOVA, and multiple regression analysis, using a
significance level of .05 for all analyses.
Definitions
I used the following definitions for key terms in this study:
Asians and Pacific Islanders (APIs): A population that includes people from
Japan, China, Taiwan, Southeast Asia, the Indian subcontinent, the Philippines, and other
Pacific island nations (Sue et al., 2012).
CD4 count: A measure of the number of CD4 cells, which is a type of white
blood cell that fights infection, and is typically used to measure the health of HIV/AIDS
patients (CDC, 2012).
HIV/AIDS patient: An individual with a chronic and potentially life-threatening
disease caused by human immunodeficiency virus (CDC, 2012).
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Psychotherapy: Treatment for mental health problems by psychiatrists,
psychologists, or other mental health providers (Li et al., 2012).
Psychotherapy attendance rate: The number of days the patient is present during
treatment divided by the number of total days of treatment (Li et al., 2012).
Social support: The perception that an individual is cared for and given support
by the people or groups of individuals around him (Tasca, 2014). For the purpose of this
study, this term will be defined as the presence of a case worker in psychotherapy.
Access to a case worker in the data set is identified as whether the patient was assigned a
case worker to provide support services including treatment adherence education and
assistance with navigating through the health care system.
Viral load: The measure of the amount of HIV in the blood of a patient (CDC,
2012).
Assumptions
Leedy and Omrod (2010) define an assumption at the self-evident truth about the
subject matter considered in this study. In this study, I assumed that the medical data
files available at the community health center were accurate, updated, and sufficient to
capture current conditions of APIs and non-APIs who have HIV/AIDS in the geographic
area of New York City. The use of secondary data increased the validity of a study by
ensuring that data was measured using a standard instrument. Another assumption was
that APIs live in collectivistic cultural contexts, while non-APIs lived in more
individualistic groups.
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Scope and Delimitations
Leedy and Omrod (2010) define delimitations as the boundaries of research. My
intent in this study was to examine the impact of social support and psychotherapy
attendance rates of APIs on health outcomes such as CD4 and viral load. I limited the
scope of this study to measuring social support given to people who are APIs and who
have HIV/AIDS, and studying psychotherapy as a means to treat HIV/AIDS. This study
was also delimited to API populations in New York City. I collected the study data from
the city’s only community health center, which made sure that the study’s findings can be
generalized to the total population of New York City. These results, however, may be
different from other localities, cities or states within the United States. My use of an
existing data source allowed me to collect all available data. Thus, I was able to capture a
wide range of samples within the target population.
Limitations
Leedy and Omrod (2010) define limitations as weaknesses that may exist in any
part of the research. One limitation in the research design was that this quantitative causal
comparative study was focused on analyzing direct relationships between variables. The
findings of this study only showed relationships between variables and do not show
causality. This study did not include conclusions on the effectiveness of interventions.
Further, I have only provided conclusions on social support based on data from the
community health center reports. Another limitation of this study was that I only
considered variables captured in the data reports of a community health center.
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Significance
Through this study, I aimed to contribute to an under-researched area of possible
connections among the factors of social support, attendance rates in psychotherapy, and
health outcomes in a vulnerable population in which the HIV/AIDS infection rate is
increasing and that may have unique sociocultural needs. My aim was to discover
whether people who are APIs, have HIV/AIDS, and currently have social support have a
higher rate of participation in psychotherapy along with comparatively better health
outcomes. If the study confirms those better outcomes, those working in social services
could identify ways of providing APIs with direct, culturally-appropriate social support
with the goal of increasing their psychotherapy attendance and improving their health
outcomes. The results of this study will benefit both APIs and non-APIs who have
HIV/AIDS by providing a guide for potential programs that could be developed in order
to strengthen social support within and outside the community. These programs may help
encourage HIV/AIDS patients to seek medical treatment in order to combat the
complications of their illness.
Summary
The CDC (2012) reported a steady increase in cases of HIV/AIDS in recent years
among APIs living in the United States, indicating an increased need for medical and
mental health services for this group. APIs as a whole seek mental health care less often
than the general population (Leong et al., 2011) and have a higher dropout rate than the
general population as well (Lin, 1994). The purpose of this quantitative causal
comparative study was to examine the psychotherapy attendance rates among API and
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non-API HIV/AIDS patients and among APIs and non-APIs not diagnosed with
HIV/AIDS in order to identify the impact of social support on attendance rates and health
outcomes such as CD4 and viral load. I used a non-experimental causal comparative
research design to investigate whether relationships exist between identified independent
and dependent variables. The data collected for this study included patient demographics,
diagnosis, adherence to medical and psychotherapy appointments, and access to social
support contained in anonymous medical files of HIV/AIDS patients at a community
health center. I analyzed the gathered data using descriptive and inferential statistics
including factorial ANOVA, repeated measures ANOVA, and multiple regression
analysis. In the next chapter, I will present a review of current literature on the study
subject.
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Chapter 2: Literature Review
Introduction
This chapter contains a review of the literature related to this study on the impact
of social support on psychotherapy participation among APIs who have been diagnosed
with HIV/AIDS. There has been little research on API cultures and their attitudes toward
HIV/AIDS and psychotherapy (Hall et al., 2011; Kang et al., 2006; Leong et al., 2011;
Miller et al., 2011). Further, there has been minimal scholarly discussion of the
relationship between social support and treatment adherence (including psychotherapy
attendance) among APIs.
Irvine et al. (2015) investigated the relationship between social support and the
willingness of HIV/AIDS patients in the general population to comply with medical
treatment. Mutchler et al. (2011), O’Laughlin et al. (2012), and Westmaas et al. (2010)
showed that social support, including support from family, friends, and caseworkers,
helps to increase treatment adherence and promote positive health behaviors among the
general population with medical conditions other than HIV/AIDS. Yeun et al. (2013)
examined SCT and health-promotion behavior in API patients who were not diagnosed
with HIV/AIDS and found a positive correlation between treatment adherence and social
support in the form of treatment education and self-management related to their illness.
These and similar findings in the literature have confirmed the links among social
support, receptivity to mental health care and psychotherapy attendance, and health
outcomes. Moreover, researchers have found that specific characteristics of Asian
cultures result in attitudes and behaviors toward HIV/AIDS and toward seeking and
	
  

15	
  

remaining in mental health care that are different from non-Asian cultures. Those
findings show the need for specific attention to the API individuals who have been
diagnosed with HIV/AIDS.
According to the Health Resources and Service Administration (2009), people
living with HIV/AIDS experience some type of psychiatric disorder at a rate four to eight
times higher than the general population, including as many as 60% who experience
depression. Scholars have suggested that short-term psychotherapy (24 sessions or fewer)
reduces depression and anxiety in HIV/AIDS patients (Himelhoch et al., 2007; Pobuda et
al., 2008). Because psychiatric disorders are often a barrier to medical treatment
adherenc, researchers have indicated that HIV/AIDS patients who receive psychotherapy
have better health outcomes. Social support is one of the factors that researchers have
identified as leading people to seek and remain in psychotherapy (Irvine et al., 2015;
Yeun et al., 2013). Moreover, social support generally promotes positive health
outcomes, including higher treatment adherence rates (Irvine et al., 2015; Mutchler et al.,
2011; O’Laughlin et al., 2012; Westmaas et al., 2010). It is therefore possible to predict
better medical outcomes for HIV/AIDS patients who have social support and who attend
psychotherapy.
The CDC (2012) reported a steady increase in HIV/AIDS cases among APIs in
recent years, indicating an increased need for medical and mental health services for this
group. Specific cultural factors, however, often dissuade APIs from seeking and
remaining in medical treatment and psychotherapy due to stigmas in Asian cultures
regarding HIV/AIDS (Kang et al., 2006; Sue et al., 2012), regarding mental disorders,
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and regarding resistance to seeking help outside the API community. The result is that
APIs seek mental health care less often (Leong et al., 2011) and have a higher dropout
rate (Lin, 1994) than the general population. There is currently little data on the initial
psychotherapy attendance or the psychotherapy dropout rates of API patients with
HIV/AIDS (Kang et al., 2006; Sue et al., 2012).
In this chapter, I discuss my literature review strategy and then explain the
recommended medical treatment for people with HIV/AIDs. I discuss social cognitive
theory, including its background, the rationale and implications of it, and its relevance to
my study. I review literature on depression, psychotherapy, and social support, and
present operational definitions for the study. I conclude with a summary of the chapter in
which I identify themes and gaps in literature and offer recommendations.
Literature Review Strategy
For this study, I conducted a search of the literature published from 1986 through
2015 and focused on APIs, HIV/AIDS, and psychotherapy participation. I gathered this
literature through the Walden University library using a range of academic databases:
CINAHL Plus with Full Text, ERIC, MEDLINE with Full Text, ProQuest Nursing and
Allied Health Source, PsycARTICLES, and PsycINFO. My search included approved
dissertations. I also conducted Internet searches using Bing, Google, and Google Scholar
search engines, as well as a variety of governmental Internet resources including the
CDC, the New York State Department of Health AIDS Institute, and the Health
Resources and Service Administration. The Internet searches also included various
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organizations within the U.S. Department of Health and Human Services, such as the
AIDS Info Project and the AIDS.gov website.
The literature search included the following key words and phrases: Bandura’s
(1989) social cognitive theory (SCT) mental health treatment, HIV/AIDS treatment, Asian
and Pacific Islanders, Asian and Pacific Islanders and mental health, psychotherapy
attendance rate, psychotherapy dropout rate, social support, and treatment adherence.
The search continued with combinations of those key words and phrases mentioned
above with SCT or social support. For example, I combined the key words Asian and
Pacific Islanders and mental health with social support; social cognitive theory with
treatment adherence; HIV/AIDS treatment with social support; and psychotherapy
attendance rate with Asian and Pacific Islanders.
Recommended Medical Treatment for People with HIV/AIDS
The CDC (2014a) has recommended that individuals diagnosed with HIV/AIDS
initiate antiretroviral therapy (ART) within three months of diagnosis, and visit their
primary care physician at least every six months. The Panel on Antiretroviral Guidelines
for Adults and Adolescents (PAGAA, 2015) of the U.S. Department of Health and
Human Services (HHS, 2014) recommended that patients follow up with a physician
within eight weeks and every three months thereafter, once ART is initiated, to monitor
viral load suppression and CD4 counts, as well as to detect any drug resistance that could
be harmful to the patient. The CDC (2014a) and HHS (PAGAA, 2015) have both stressed
the importance of initiating ART at an early stage of diagnosis and stressed patient
compliance with ART (a minimum 95% adherence) to extend the lifespan. Brown,
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Littlewood, and Vanable (2013) confirmed the necessity of 95% or higher treatment
adherence because it is associated with optimal viral-load suppression and reduces the
risk of disease progression.
HIV/AIDS is now considered a chronic illness similar to diabetes or hypertension,
with longer life expectancy accompanying treatment adherence.; However, individuals
diagnosed with HIV/AIDS often face mental health symptoms such as depression (Nokes
et al., 2012) that can affect treatment adherence. The CDC (2014a) recommended that
physicians monitor barriers such as depression that may interrupt treatment adherence.
The HHS (2014) and Sin and DiMatteo (2014) have pointed out that HIV/AIDS patients
are at increased risk of developing at least one psychiatric disorder, such as depression,
that leads to low adherence. Low adherence or no treatment are likely to result in
unsuppressed viral load and high CD4, which cause other opportunistic infections that
can lead to death. When psychological issues are addressed, patients are more likely to
adhere to ART (Sin & DiMatteo, 2014). Due to the prevalence of mental illness among
HIV/AIDS patients, the AIDS Institute (2012) recommended that physicians conduct a
mental health screening at every visit for depression, suicidal or violent ideation, sleep
habits, and appetite. The institute also suggested that patients be assessed at least
annually for cognitive function, psychosocial status, and alcohol and substance use to
ensure early detection of possible barriers to HIV/AIDS treatment.
Bandura’s (1989) Social Cognitive Theory (SCT)
According to Bandura’s (1977) social learning theory, individual behavior is
learned and changed through environmental influences (McLeod, 2011). For example, a
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child sees a teacher pick up toys and return them to the toy chest. Imitating the teacher,
the child helps the teacher pick up the toys and returns them to the chest. The teacher says
“What a good girl you are! Thank you!” The child experiences this response as
rewarding, making it more likely that she will repeat the behavior due to the external
positive reinforcement (McLeod, 2011). Both positive and negative reinforcement can
lead to behavioral change (McLeod, 2011; Rosenstock, Strecher, & Becker, 1988). Social
learning theory was later relabeled social cognitive theory (SCT) to focus on the
individual’s expectancies and incentives (Rosenstock et al., 1988).
SCT describes three categories of behavior consequences, called expectancies,
that individuals anticipate and respond to: environmental cues, outcome, and self-efficacy
(Rosenstock et al., 1988, p. 177). The first expectancy, environmental cues, influence
behavior by teaching individuals how events connect to each other. The second
expectancy, outcome, is based on how the individual’s behavior impacts the end result,
which leads him/her to anticipate the response to an action. The third expectancy, selfefficacy, is the individual’s confidence in being able to complete the assigned task or
change in behavior (Rosenstock et al., 1988). SCT also points to incentives or
reinforcement—such as improved physical appearance or health status—that contribute
to the value people place on outcomes, serving as motivation to complete a task or
change behavior (Dilorio et al., 2009; Rosenstock et al., 1988). In the next section, I
explain why I used this theory for my study.
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Rationale for SCT
SCT is pertinent to understanding health behaviors, because the identified
expectancies influence a patient’s efforts to improve health. Individuals’ perceptions of
their ability to adopt certain behaviors such as treatment compliance (self-efficacy), the
environmental support available to them to do that, and the outcome of their behavior
influences their decisions and behaviors..
Outcome expectancy is an important source of motivation and incentive in
decision-making and task completion (Bandura, 1989). People commit to behavioral
changes based on their perception of the possible outcomes of their actions (Bandura,
1989). For example, if they perceive positive outcomes from attending psychotherapy,
such as feeling more empowered in their life, they may be less likely to drop out of
therapy. Longo et al. (1992) found that, depending on treatment type and setting,
psychotherapy dropout rates range from 20% to 60%, and that at least 25% do not return
after the initial appointment. In their study, when 104 participants were informed about
the treatment process and the possible benefits from it, 85% (n = 88) continued with the
psychotherapy sessions. The authors suggested that strengthening outcome expectations
can have a positive impact on treatment adherence.
Bandura (1989) noted that thoughts often affect behavior, especially the
individual’s perception of self-efficacy for accomplishing a task or making changes.
Bandura argued that individuals’ judgments of their capabilities can be either “selfhindering or self-enhancing” (p. 60). How they evaluate their capabilities is very
important, “because acting on misjudgments of personal efficacy can produce adverse
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consequences, [while] accurate appraisal of one’s own capabilities has considerable
functional value” (Bandura, 1989, p. 59). Individuals who are not equipped with skill sets
that help them cope with life or who are filled with self-doubts often have low selfefficacy, which may lead to difficulties in adapting or making changes (Bandura, 1989).
Bandura (1989) defined self-efficacy as the ability of an individual to succeed in
accomplishing a certain task. Johnson et al. (2007) confirmed that self-efficacy is an
important component in health behavior and has a strong connection to treatment
adherence. These researchers used the Adherence Self-Efficacy Scale (ASES) to measure
self-efficacy for HIV treatment adherence, and found that individuals with high ASES
scores experienced lower depression and had better problem-solving skills, resulting in
higher adherence to medical treatment. Individuals with low self-efficacy, however, were
less likely to attend medical appointments or follow up with treatment, which might
result in more emergency room visits. In the next section, I discuss the effects of using
SCT in relation to treatment for HIV/AIDS.
Implications of SCT for Treatment Adherence
SCT suggests that personal experiences, knowledge, and environment have an
impact on an individual’s behavior (Dilorio et al., 2009; Yeun et al., 2013). Those three
factors can influence a person’s feelings of self-efficacy and influence the person’s
adherence to treatment. Dilorio et al. (2009) suggested that individuals with strong selfefficacy are likely to succeed at difficult tasks such as changing their behavior due to
their perseverance. Zebracki and Drotar (2004) conducted a study on children and
adolescents ages 7 to 17 who were diagnosed with asthma. The study focused on
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outcome expectancy and self-efficacy in relation to treatment adherence. The researchers
found that those with high self-efficacy were more compliant with asthma treatment
compared to those with low self-efficacy. They also found that children and adolescents
with overly optimistic outcome expectancies were likely to have low treatment adherence
and present with worse asthma symptoms, confirming the relationship between selfefficacy and health outcomes.
A number of studies have examined ART adherence and self-efficacy. Dilorio et
al. (2009) examined several studies of ART adherence and found that they showed that
“higher levels of self-efficacy correspond to higher rates of ART adherence” (Dilorio et
al., 2009, p. 11). On the other hand, those with low self-efficacy were likely to have
demoralizing ideation that led to low ART adherence (Dilorio et al., 2009). Dilorio et al.
(2009), Zbracki and Drotar (2004), and Yeun et al. (2013) confirmed that individuals
with high self-efficacy have better treatment compliance rates.
Relation of SCT to the Current Study
Bandura’s (1989) social cognitive theory provides a theoretical framework for the
study of social support and its effects on treatment adherence and health outcomes. SCT
explains how behavior is influenced by an individual’s knowledge and experiences that
come from personal and environmental influences such as family and the media (Yeun et
al., 2013). One method for increasing initial psychotherapy attendance and decreasing
psychotherapy dropout rates in APIs who have HIV/AIDS may be found in the social
support component of Bandura’s SCT. Individuals and groups continually strive to seek
closeness with other individuals or groups to feel secure (Tasca, 2014; Yeun et al., 2013).
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Social support also has a significant impact on self-efficacy, one of the key elements of
SCT that motivates people to change their behavior (Longo et al., 1992; Wood &
Bandura, 1989). Researchers shown that social support can also lead to specific concrete
behavioral changes, including seeking and remaining in treatment, especially for
individuals with chronic disease (Longo et al., 1992; Shen et al., 2012). There is
sufficient data in the literature to confirm that HIV/AIDS patients who have strong social
and emotional support and bonds with other individuals and with groups have
significantly higher medical treatment adherence (Irvine et al., 2015; Li et al., 2012;
Stubbs et al., 2009; Ushie & Jegede, 2012). It is possible that increased self-efficacy,
positively impacted by this social support, is also a factor in treatment adherence.
Current Empirical Literature Relevant to Research Questions
The psychiatric disorders commonly experienced by individuals with HIV include
psychotic disorders, mood disorders, sleep disorders, and personality disorders, which
could be pre-existing or develop after diagnosis (Health Resources and Service
AdministrationA, 2011). Suicidal ideation is usually reported within 6 months from the
time of diagnosis (Glass, 1988). The psychological problems experienced by individuals
with HIV are a result of shame, humiliation, guilt, stigmatization, fear, embarrassment,
and anger about having HIV/AIDS. These can manifest in different areas of a patient’s
life. The literature review of the study presented in the succeeding sections will discuss
the important issues of psychotherapy, depression, and social support for individuals
diagnosed with HIV. To better understand HIV patients in terms of how they approach
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their condition, I will review perceptions of HIV/AID and the attitudes toward its
treatment.
Attitudes toward Treatment of HIV/AIDS
There are many factors that contribute to individuals with HIV seeking medical
care or avoiding treatment (Oppenheimer, 2008). These are often affected by the
emotional problems of the individuals, as well as the substances they use. Turner-Cobb et
al. (2002) found that individuals who are well-adjusted to chronic illness such as
HIV/AIDs were those who did not deny their illness, and decided instead to cope with it
and with the stressors that come along with their diagnosis. Some of the coping
mechanisms include receiving positive social support, participating in peer support
groups, seeking mental health services, implementing help from caseworkers, seeking
information to manage the virus, following medication regimens, implementing the help
caretakers to help with daily activities, and seeking organizational support (Turner-Cobb
et al., 2002). Positive thinking or having a positive state of mind is also often related to
better adjustment and coping (Folkman, 1997). Adherence to medication regimens
increases adjustment to living with HIV/AIDS (Turner-Cobb et al., 2002).
Kim et al. (2007) found that the discontinuation of medication is prevalent among
those who have an alcohol problem, as well as those who exhibit depressive symptoms
without substance abuse. Another study found that a lack of confidence in the
effectiveness of medication is one of the reasons for failing to consistently follow a
medication regimen (Locher, Wayson, Pargament, & Duggan, 2007). The study
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participants indicated that they find the medication a constant reminder of their illness.
Many also noted that the medications are time-consuming and energy-restricting.
Another factor affecting HIV treatment is patient-client relationship
(Oppenheimer, 2008). A study of the factors determining adherence to treatment showed
that patient perceptions of being valued and respected by the clinician, the ability of
patients to discuss concerns with the clinician, and the level of trust and empowerment
felt by the patient were the main predictors of whether patients continued with medical
treatment (Molassiotis, Morris, & Trueman, 2007). Molassiotis et al. suggested that
investing in communication techniques to improve relationships with patients may
improve the maintenance of medical treatment.
DiMatteo (2004) stated that attitudes toward treatment and adherence to the
treatment depend on a patient’s acceptance of the diagnosis and ability to follow through
with treatment recommendations. DiMateo found that asmuch as 40% of noncompliance
to medical treatment may be due to the lack of practical and emotional support, such as
health insurance and childcare. Among patients who lacked practical support, a
noncompliance rate of 65% or more could be expected. The CDC (2014b) and
Bhattacharya (2004) indicated that early access to medical care is critical in treating and
preventing illness such as HIV/AIDS and depression.
Factors that negatively affect adherence to treatment include feelings of fear, pain,
fatigue, and social isolation (Oppenheimer, 2008). Based on the information from the
Stanford Patient Education Research Center (SPERC), individuals with HIV identified
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many concerns regarding educational and emotional support. Some of these issues
include the following:
1. deficits in their knowledge about how to integrate medication regimens into
their daily schedules;
2. questions about how the best ways to deal with frustration, fatigue, and pain
management;
3. fear of the implications of the illness;
4. concerns about how to communicate effectively with family, friends and
health professionals;
5. a need for nutritional support;
6. a need to understand how to plan for advanced directives; and
7. a need for knowledge about how to evaluate both symptoms and new or
alternative treatments. (Oppenheimer, 2008, p.17)
The SPERC emphasized the significance of social support and its impact onn
achieving the goals of the educational curriculum and support system (HIV/AIDS
Education, Prevention, and Services Programs, 2007). Patient attitudes are affected by
how the patient views the medical diagnosis.
Perception of Medical Diagnosis among API
A patient’s perception of a medical diagnosis or illness can impact self-efficacy and
subsequently treatment adherence (Bean, Cundy, & Petrie, 2007). Donkin et al. (2006)
found that even when health education is provided to API individuals, they continue to
actively search for confirmatory evidence to support their preexisting beliefs because the
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information given to them may cause discomfort or go against their beliefs. These
researchers suggested that perceptions of illness are often based on beliefs that are
influenced by family, culture, and past experiences. Bhattacharya (2004) found that this
is especially true in Asian communities. A few studies focused on the perception of
Asians and Pacific Islanders on mental health and health concerns.
Bean et al. (2007) conducted a study on perception of Type-2 diabetes among 259
patients in South Asia, the Pacific Islands, and Europe. The researchers used the Brief
Illness Perceptions Questionnaires to measure participants’ perceptions of their medical
diagnoses. The researchers found that fewer Pacific Islanders and South Asians accepted
their diagnosis compared to Europeans, and they often perceived the illness to be less
serious, which led to minimal or no compliance with treatment. With respect to mental
health, APIs often refer to physical symptoms such as headache or eye pain rather than
depression, or speak about behavioral problems instead of psychiatric problems
(Greenwood, Hussain, Burns, & Raphael, 2000). Hatfield, Mohamad, Rahim, and
Tanweer (1996) explored perceptions and treatment of mental health among 106 API
patients in England, of whom 100 identified as Muslim. Hatfield et al. found that API
males have a more positive view of Western treatment than females, but tend to favor
Eastern treatments such as herbal medicine or acupuncture.
Bhattacharya (2004) argued that APIs are unwilling to seek medical care or that
they delay the process until an advanced stage of illness because of barriers in health
literacy, the stigma of the illness, or financial burden. Hall et al. (2011) emphasized the
dependence of Asianindividuals on their family, friends, and community for resolving
	
  

28	
  

issues. Hall et al. reported that unlike European andAmerican cultures, Asian cultures do
not encourage direct communication with those outside the community. Kang et al.
(2006) described close communication among those within the API community, but
noted community pressure on Asians with HIV/AIDS to not disclose their illness and to
not seek medical or psychological treatment. Bhattacharya (2004) pointed out that South
Asians are especially encouraged to seek Eastern medical care such as herbal medicine
and to visit religious healers before accessing Western medicine. Kang et al. (2006)
found that APIs who have been diagnosed with HIV/AIDS often suffer from depression
and other psychological consequences. Following these sections on attitude and
perception of individuals, the review will cover depression as it relates to medical
condition/diagnosis.
Depression
Mental illness and depression are prevalent in individuals who have been
diagnosed with HIV/AIDS (Beer et al., 2009; Knowlton et al., 2010). Depression
symptoms and mental health care status among individuals with HIV/AIDS are common
factors that contribute to missing health care appointments (Uphold & Mkanta, 2005).
Uphold and Mkanta cite depression is the second leading cause of hospitalization among
HIV patients, and report that depression symptoms can affect the motivation of a patient
to pursue medical care and continue with regular visits to clinics or hospitals.
Psychological disturbance is harmful to individuals with HIV. Leserman et al.
(1999) noted that greater depressive symptoms, increases in stressful life events, and low
social support accelerates the progress of AIDS. Vedhara, ott, Bradbeer and Davidson
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(2007) identified emotional distress as a significant predictor of disease progression. The
results of their study align with the earlier findings of Burack et al. (1993) that there is
greater decline in CD4 counts of depressed HIV patients compared with those who are
not depressed. These results indicated that depressive symptoms, in interaction with life
adversity, predict a decline in the percentage of CD4 cells. Evans et al. (1997) noted that
having a major depressive disorder reduced the number of natural killer cells. Pessimism
was related to depressed mood, to lower numbers of helper T-cells, and to lower levels of
natural killer cell activity (Segerstrom, Taylor, Kemeny, & Fahey, 1998).
There are many barriers that keep patients with HIV from seeking medical care.
For example, the stigma of HIV may keep individuals from taking immediate steps to be
tested. Such individuals have low self-esteem and poor antiretroviral compliance and
experience depression, anxiety, or hopelessness (Zukoski & Thorbum, 2009). The
barriers to medical care experienced by individuals with HIV may result in health gaps
linked to co-occurring mental and substance abuse disorders (Bradford, Coleman, &
Cunningham, 2007).
Definition of Depression
Depression is a disease with a number of “core” symptoms. Symptoms may
include a lowering of mood to the extent that would be considered abnormal, as well as a
loss of interest in or decrease in enjoyment of normally pleasurable activities (Mugford,
2002).
In order to adhere to the depression criteria laid out by the International Statistical
Classification of Diseases and Related Health Problems, Tenth Edition (ICD-10), two of
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those core symptoms need to be present for at least two weeks. There are other symptoms
that could help confirm the diagnosis of depression (Mugford, 2002), including feelings
of guilt, changes in sleep patterns, loss of confidence, poor concentration, thoughts of
suicide, appetite changes, and agitation or retardation.
There are different levels of depression. Mild depression is present when there
four symptoms from the list, moderate depression should have at least six symptoms
present, and having eight symptoms present would indicate severe depression (Mugford,
2002).
Depression and HIV
A depressed mood is very common in individuals with HIV/AIDS – in fact, it is
the most common neuropsychiatric complaint of individuals with HIV/AIDS who seek
psychiatric evaluation (Halman, 2001). Depression is also one of the major factors linked
to a decreased quality of life in patients with HIV/AIDS. A severe or major depression
could lead to suicide in HIV patients, as major depression is considered a primary risk
factor for suicide (Fawcett et al., 1990; Rundell et al., 1992). According to Mayne,
Vittinghoff, Chesney, Barrett, and Coates (1996) and Evans et al. (1997), the decreased
survival of individuals with HIV disease and decreased immunological function has been
linked to major depression. The following sections will discuss the approaches to
treatment in relation to HIV.
Psychotherapy
There is clear evidence of psychotherapy’s role in the management of HIV
disease. Clinical experience and some systematic studies have proposed that
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psychotherapy alone or psychotherapy combined with antidepressant drug therapy can
result to significant benefits in treating HIV patients (Perry, 1994). Brouillette and Citron
(1997) argued that “Given the nature of this illness and the stresses associated with it,
psychotherapy should be an integral part of psychiatric care for someone living with
HIV” (p. 57).
Over the years, psychotherapy has taken a more significance place in the
management of chronic illnesses. Healthcare providers have reported improved clinical
outcomes for patients whose psychological well-being is addressed as part of the
treatment (Irvine et al., 2015; Kim, Zane, & Blozis, 2012). The growing number of
clinical trials that examine quality of life outcome measures serves as evidence that there
is an increase in the attention provided to the psychosocial aspects of health care.
Psychotherapy has the ability to enhance the stress management skills and coping
mechanisms of individuals with HIV/AIDS (Astin, 1997; Balter & Unger, 1997). It has
been used with a variety of models to help manage the stress of individuals with HIV and
help them cope with their psychosocial issues (Mugford, 2002). Psychotherapy is
believed to be beneficial to patients with HIV who responded well to the new highly
active anti-retroviral therapies (HAART; Farber & McDaniel, 1999). Psychotherapy can
help patients to explore changing self-perceptions and role definitions, balance hope and
concern about the future, and cope with possible survivor guilt. Psychotherapy is also
beneficial even to those who did not respond well to HAART, because it can help
patients process the “loss of hope, anxiety, sadness, grief and anger associated with a
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sense of being without options at a time when the HIV/AIDS community is optimistic
about survivability” (Farber & McDaniel, 1999, p. 177).
Sue, McKinney, and Allen (1976) investigated community health centers to
identify the dropout rates for psychotherapy attendance. Among the 2,551 cases included
in the study, 40.8% failed to follow through after their initial intake session. Those results
are echoed in the study by Wierzbicki and Pekarnik (1993), which found especially high
dropout rates for HIV patients in psychiatric clinics. Forty-five percent of the patients
who had initial sessions did not return, while 50% of the patients referred to the clinic did
not show up.
Yalom (1997) pointed out that the last decade of the 20th century has seen an
increasingde-stigmatization of psychotherapy, and an increasing in its role: Yalom writes:
“Psychotherapy was becoming more mainstream, more available, and more acceptable to
larger segments of the American public” (p. 9). Yalom has also pointed out the increasing
intolerance of the harmful long-term effects of trauma, the growing demand for the public
to be able to access counselling facilities, and provisions in health care plan that provide
for adequate counselling services (Yalom, 1997, p. 10). Professional experts in the field
of psychotherapy are stressing the need for an increased role for psychotherapy in the
management of chronic diseases (Gabbard, 1994; Shea, 1998; Yalom, 1997).
Definition of Psychotherapy
Psychotherapy has several definitions, depending on the conceptual framework
and the theorist. The definitions that will be provided are from the texts Standards and
Guidelines for the Psychotherapies (Cameron, Ennis, & Deadman, 1998) and
	
  

33	
  

Psychodynamic Psychiatry in Clinical Practice, The DSM-IV Edition (Gabbard, 1994).
Wolberg (1977), after reviewing several definitions of psychotherapy, provided the
following definition:
Psychotherapy is the treatment, by psychological means, of problems of an
emotional nature in which a trained person deliberately establishes a professional
relationship with the patient with the object of (1) removing, modifying, or
retarding existing symptoms, (2) mediating disturbed patterns of behavior, and (3)
promoting positive personality and development (p. 3).
The Canadian Psychiatric Association (CPA) and the Ontario Hospital Insurance
Plan provided an incomplete definition. The problem with this definition is the emphasis
on who delivers psychotherapy. The CPA indicated that it should be delivered by a
physician and not just a “suitably trained person” as often indicated in general
frameworks. For Bloye and Davies (1999), psychotherapy is a treatment during which
psychological symptoms are managed through a professional relationship between a
patient and a therapist in order to influence and alter the feelings, cognition, and behavior
of the patient.
Landau (1986) identified the role of a “suitably trained person” in providing
psychotherapy. This definition does not limit the use of psychotherapy by including just a
physician as therapist:
Any form of treatment for mental disorders or emotional disturbances in which a
suitably trained person establishes a professional relationship with an identified
patient for the purpose of removing or modifying symptoms of the disorder, or of
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promoting character growth and development so as to strengthen the patient’s
ability to cope with the problems of living. The relationship established between
patient and therapist is used to influence the patient to unlearn old, maladaptive
patterns and to learn and test new approaches. Psychotherapy includes guidance,
counselling, psychoanalysis, behavior therapy, conditioning, hypnotherapy, and
all other forms of treatment in which the major technique employed is
communication, rather than drugs or other somatic agents (p. 2348).
Types of Psychotherapies
This section discusses the different types of psychotherapies in order to provide
an overview on the approaches used on patients when providing them psychotherapy. It
allows the readers to have an understanding on the ways thathow the different types of
therapies are applied to patients. In this section, I will also discuss the approach that is
most applicable to HIV patients.
Cognitive behavioral therapy (CBT). This type of therapy is focused on
identifying dysfunctional cognitive structures that maintain unrealistic thoughts and
images in specific situations. The perception of events facilitates the response and
determines the quality of adaptation. The treatment is focused on assisting patients to
recognize perceptual and cognitive errors, become more realistic in perceiving external
problems and assist them to cope with more realistic perceived situations (Antony &
Swinson, 1998). The primary goal of this therapy is to alter or remove existing
maladaptive behaviors and replace them with new adaptive behaviors by helping patients
acquire these new adaptive behaviors (Antony & Swinson, 1998). The change in the
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thoughts and behaviors of patients are believed to be the instrument of change in CBT.
These changes are believed to result in decreased stress and more effective interactions
with others.
This type of psychotherapy is most commonly used for stress management with
individuals who have HIV. It is anchored in problem-focused activities that include the
following:
1. problem-solving techniques (e.g., learning how to go from point A to point B
by the shortest, least painful means);
2. assertive behaviors (e.g., standing up for one's rights, expressing one’s needs,
and operating with effective communication skills); and
3. seeking out help from external sources for information (e.g., approaching
other members of an individual's network of family or friends for help with a
difficult situation; Edwards, 2000, p. 47)
Psychodynamic psychotherapy. Psychodynamic psychotherapy is expressed
through five core concepts: the influence of early-childhood experiences on current adult
functioning; the power of unconscious functioning in human behavior; the reliance on
ego defenses; repetition compulsion; and transference (Book, 1998). This type of therapy
works on an expressive-supportive continuum. The primary goal of this kind of
psychotherapy is to increase the understanding of internal conflicts, deficits, and
defensive compromises of the patient. This method seeks to increase awareness, which
could result in both symptom relief as well as personality change.
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Experiential psychotherapy. This type of psychotherapy aims to share feelings
and experiences in a non-authoritarian and empathic environment (Freebury, Ennis,
Rideout, & Wright, 1998). This kind of therapy is primarily ahistorical, with emphasis on
the “here and now” experience. The strategies used for this therapy include abreaction
empathy, identification, sharing, imitation, and confrontation.
Of the three types of psychotherapy detailed above, cognitive behavior therapy
most directly applies to the population of this study since there is a need to assist HIV
patients in coping with their situation. New adaptive behaviors need to be created, and
existing behaviors need to be removed, in order to effectively help patients cope with and
adapt to their situation.
Psychodynamic therapy, with its goal of bringing the mind to consciousness, also
relates to the study population since the approach helps patients discover and understand
their real feelings so that they can address and resolve them. Patients face the reality of
their situations and can then accept and process the situations as the therapy breaks down
defenses like denial and projection.
Experiential psychotherapy is not as related to the population of the study due to
the approach and the nature of this kind of therapy. The approach for experiential is on
the “here and now” experience, which is not as applicable to patients with HIV.
Psychotherapy and HIV
Those involved in treating patients with HIV/AIDS commonly report symptoms
of mood disturbances in their patients (Brouillette & Citron, 1997). Individuals with
HIV/AIDS may experience different neuropsychiatric symptoms such as anxiety, suicidal
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ideation, irritability, insomnia, and a depressed mood (Halman, 2001). Yalom (1997)
reported that being diagnosed with HIV infection is likely to result in a strong emotional
reaction from the patient. The diagnosis can raise previously unresolved concerns and
even bring up historical traumas. Living with HIV/AIDS means that the individual faces
a series of crises that may overwhelm them and their coping ability. Yalom (1997) also
indicated that patients who have had previous psychiatric symptoms are more likely to
experience symptoms after HIV infection.
HIV has different effects on different individuals. One of the many outcomes of
the diseases is a repetitive cycle of denial and hopelessness, as patients experience
cyclical changes in both physical and psychological condition from good health to poor
health and back again (Ostrow, 1997). As Ostrow pointed out, “There is an inherent
affective instability that comes with HIV infection and with attempts to gain control over
its seemingly inevitable encroachment.” (1997, p. 34).
Patients with HIV experience many declines in their health and mental sharpness,
in their social networks, and in their autonomy and economic security (Mugford, 2002).
These losses oftentimes happen simultaneously or in rapid succession, which results in
decreased psychological well-being (Ostrow, 1997). Those who manage individuals with
HIV/AIDS observe demoralization in the patients (Treisman, Angelino, & Hutton, 2001).
Demoralization is an exaggerated grief state where the patient has persistent feeling of
sadness, hopeless or low mood that hinders their usual activities. This is different from
depression, because it is not a brain disease and does not respond to antidepressant
medication, but does respond to psychotherapy (Mugford, 2002).
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Psychotherapy Participation by APIs
An individual’s ethnicity is a somewhat consistent predictor of attrition in
psychotherapy programs (Nevid, Javier, & Moulton, 1996). Researchers have found that
individuals with HIV from ethnic minorities were less compliant about attending medical
appointments (Catz, McClure, Jones, & Brantley, 1996). Ethnicity has been identified in
several studies as a significant factor in the duration of psychotherapy, and scholars have
pointed out that ethnic minorities usually terminate their sessions early (Constantine,
2002; Maramba & Nagayama-Hall, 2002).
Providing culturally sensitive psychotherapy sessions that are meaningful and
effective for patients can affect treatment adherence (Tseng, 2004). Asian communities
are likely to view psychotherapy as “disgraceful” for themselves and their family and
consider “talk therapy” to be “useless” (Tseng, 2004, p. 153). As a result, Asians are less
likely to seek therapy. Bhattacharya (2004) added that racial and ethnic minority groups
such as blacks and Asians have a much lower rate of accessing mental health care
compared to caucasians. Researchers who performed studies using unspecified
populations in outpatient settings found that, on average, between 30% and 40% of
individuals referred to psychotherapy never show up for their appointment, and those
who start treatment have an average dropout rate of 47% (Fenger, Mortensen, Poulsen, &
Lau, 2011).
Leong et al. (2011) and Miller et al. (2011) explored how acculturation impacts
receptivity toward psychotherapy, finding that it has minimal impact on Asian college
students. In addition, these researchers showed that the cultural fear of loss of face has a
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significant impact on attitudes toward seeking mental health care. Fenger et al. (2011)
also found that individuals who do not adhere to psychotherapy are likely to struggle with
a lack of social support such as health education and health insurance. Social support was
mentioned in this section as a factor in psychotherapy. In the next section, I will discuss
social support in relation to HIV treatment and care.
Social Support
Social support is considered as an enabling factor for engaging in HIV care
(Johnson et al., 2003). Researchers have noted that patients with HIV can benefit from
social support to deal with their medical situation. The support received by patients with
HIV helps them deal with and adjust to their disease (Ciambrone, 2002; Knowlton, Hua,
& Latkin, 2005; Tsasis, 2000). Social support can help address and reduce depression
and, anxiety, increase adherence to HIV-related treatments and medication, and improve
quality of life (Cox, 2002; Knowlton et al., 2005).
Patients with HIV turn first to the network of social support that includes family
and friends. For some individuals, social support from family and friends is not available
because of geographic distance or because the patients have not disclosed the illness to
family and friends (Serovich, Brucker, & Kimberly, 2000; Turner-Cobb et al., 2003).
Some researchers have suggested that social support from hospice care workers and from
home health nurses may actually have greater importance for patients infected with HIV
than social support from family and friends (Tsasis, 2000).
It is important to identify the kinds of support that are most effective in helping
patients. Based on literature, support comes in two varieties: formal and informal. Formal
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support consists of help provided through professional support systems such as health
care and social service providers, while informal support consists of help provided by
family, friends, and community organizations like the church (Waddel & Messeri, 2006).
While family support is critical for a patient’s motivation to enter medical care, the
perceived and actual stigma evident in the patient’s social and community environment
often results in hesitation about asking and/or receiving support (Klitzman et al., 2004).
As a result, non-family social support takes a more important role.
A good support system of family or friends may contribute to the willingness and
motivation of a patient to sustaining their current health status by using available health
care services (Fattal, Lampe, Barcelona, & Muzina, 2005). A study by Pillai, Kupprat,
and Halkitis (2009) on the effect support has on accessing medical care showed that
individuals who had somebody with them in the house reported higher scores in terms of
access to care compared to those who lived alone. Cote, Godin, Garcia, Gagnon, and
Rouleau (2008) and Mosack and Petroll (2009) indicated that individuals who receive
support from spouses, significant others, or family members are more likely to continue
with medical appointments and take their medications.
A qualitative study by Mosack and Petroll (2009) of individuals who had HIV and
were in a committed relationship analyzed the importance of having someone with them
during medical appointments. Based on the responses, including other individuals in their
appointments and treatments yielded more positive results than negative ones. Patients
reaped advantages including improved family health, improved information
communication, strengthened relationships, and enhanced treatment outcomes. The
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involvement of other individuals in the treatment of a patient with HIV leads to better
treatment plan compliance, as evident in consistent appointment attendance and
medication adherence (Mosack & Petroll, 2009). The negative result of involving other
individuals in a patient’s medical appointment and treatment included the possibility of
family members dominating discussions due to their anger, or focusing on topics such as
mode of transmission. As a result, patients became more hesitant about discussing certain
topics and tended to be less honest (Moscak & Petroll, 2009).
Social support from family members has a positive effect on the general health
and well-being of patients with HIV/AIDS (Adams, King, & King, 1996). Family support
increases active coping styles (Holahan & Moos, 1987), and encourages participation in
positive health-related activities such as physical exercise (Sallis, 1999). The support
from family members also lessens the difficulties such as depression that individuals with
HIV/AIDS face (Terry, Mayocchi, & Hynes, 1996).
Higher levels of family support lead to increase in general informal involvement,
possibly because the time and energy devoted to the family results inelevated motivation
and in increased opportunities for reinforcement (Adams et al., 1996). Family
involvement leads to family support, which translates to positive outcomes. Given the
impact of family relations on job and life satisfaction, family involvement may also
impact satisfaction with therapy and subsequent continuation of it (Nichols & Schwartz,
2001). There is also evidence that the involvement of family members in therapy can
contribute to decline of attrition rates (Stanton & Shadish, 1997).
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Fathers are less likely to be involved in the therapeutic venue, but their presence
can result in critical implications for the effectiveness of therapy (Duhig, Phares, &
Birkeland, 2002). Some scholars have noted that the involvement of fathers increases the
probability of positive outcomes in psychotherapy (Gurman & Kniskem, 1981; Shapiro &
Budman, 1973). One of the important results of father participation is that it can enhance
maintenance and generalization of treatment gains (Duhig et al., 2002).
With the medical repercussions and stress among others that accompanies a
diagnosis of HIV/AIDS, the presence of peer relationships and social support is critical
(Rubenstein & Sorrentino, 2008). Social isolation can significantly impact individuals
with HIV/AIDS. In patients with low social participation, CD4 cell count was lower,
which suggests that social support has a positive impact on overall health (Persson,
Gullberg, Hanson, Moestrup, & Ostergren, 1994).
Access to social support can be challenging for individuals with HIV, since
family and friends usually have a hard time accepting and understanding the patient’s
situation (Rubenstein & Sorrentino, 2008). Because patients fear the reaction of others
when they disclose that they have HIV, they are reluctant to disclose information and
may avoid disclosure and social contact with family and friend, which results in reduced
social support. This situation increases the feeling of isolation and shame for the
individuals with HIV (Rubenstein & Sorrentino, 2008).
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Summary and Conclusions
Themes Found and Overall Trends Found in the Literature
A number of previous researchers have supported the notion that API
communities are insular and prefer to seek health care from within their own community
(Hatfield et al., 1996; Leong et al., 2011). If they decide to seek mental health services,
APIs are likely to have a higher dropout rate (Lin, 1994). Hatfield et al. (1996) and Irvine
et al. (2015) argued that despite study findings that APIs are less likely to seek services,
service providers should not operate under the assumption that APIs do not need help
accessing and maintaining healthcare, including mental health treatment. Social cognitive
theory shows that self-efficacy is correlated with more positive perceptions of illness
(Bean et al., 2007), which in turn increases ART adherence among HIV/AIDS patients
(Brown et al., 2013). Irvine et al. (2015) and DiMatteo (2004) found strong evidence for
the idea that social support has a positive impact on treatment adherence.
Gaps in the Literature
A limited selection of literature provides information on API cultures and their
attitudes toward HIV/AIDS and psychotherapy (Hall et al., 2011; Kang et al., 2006;
Leong et al., 2011; Miller et al., 2011). There is little information addressing API
perceptions of general medical treatment (Shen et al., 2012). There is limited discussion
in existing literature of the relationship between social support from family, friends, and
case workers and increased treatment adherence or promotion of positive health
behaviors among the general population with medical conditions other than HIV/AIDS
(Mutchler et al., 2011; O’Laughlin et al., 2012; Westmaas et al., 2010). In addition, there
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are few recent discussions of APIs who have been diagnosed with HIV/AIDS and their
psychotherapy participation. Sufficient information supports a link between health
education and HIV/AIDS treatment adherence in general (Irvine et al., 2015; Nokes et al.,
2012). And literature on health education and treatment adherence has addressed the
general population rather than Asians specifically.
In this current study, I examine the connections among social support, attendance
rates in psychotherapy, and health outcomes in a vulnerable population in which the
HIV/AIDS infection rate is increasing and that may have unique sociocultural needs. This
study focuses specifically on APIs in the United States. The study determines whether
APIs who have HIV/AIDS and have social support enjoy a higher rate of participation in
psychotherapy and comparatively better health outcomes than those without social
support.
Recommendations from the Literature on Future Research
Fenger et al. (2011) noted that, on average, between 30% and 40% of individuals
referred for mental health services in a clinical setting did not follow up by setting an
initial appointment, and those who started treatment had an average dropout rate of 47%.
Because lack of social support is a major cause of dropping out of mental health services,
future scholars should focus on social rather than psychological intervention to engage
individuals in treatment (Fenger et al., 2011, p. 189).
Brown et al. (2013) indicated that SCT concepts such as self-efficacy and
outcome expectancies have been helpful to understand the factors that promote ART
treatment adherence. Additional research should focus on sustaining positive health
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behaviors. Because high self-efficacy has a positive impact on treatment adherence,
interventions to improve self-efficacy should be further investigated and promoted
(Longo et al., 1992; Zebracki & Drotar, 2004).
While Dilorio et al. (2009) found that social support has some impact on
treatment adherence, the study did not focus on social support and therefore did not
determine the extent of the impact. Irvine et al. (2015) conducted a study on care
coordination services on and treatment adherence, finding that social support promoted
ART treatment adherence, increased patients’ satisfaction with ART, and reduced the
stigma of the treatment. Dilorio et al. (2009) recommended interventions to improve
social support and to improve treatment adherence. Because social support such as care
coordination services is deemed useful for assisting HIV/AIDS patients in initiating and
maintaining treatment, a longitudinal study should be conducted to confirm whether such
support is helpful in encouring APIs who have HIV/AIDS to adhere to psychotherapy
treatment (Irvine et al., 2015).
Literature that Challenges the Direction of this Study
Bhattacharya (2004) argued that SCT focuses on individual behavioral change
with respect to treatment adherence, with no reference to specific cultures; thus, it may
not be relevant to Asian cultures. Self-efficacy is the vital component of SCT for the
individual to implement and maintain change, but Bhattacharya noted that the theory
“lacks recognition of the interactions of factors at multiple level that may inhibit
developing self-efficacy,” such as family or cultural norms in API cultures (p. 110).
While a number of researchers have found that the stigma of mental illness prevents APIs
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from accessing treatment (Kang et al., 2006; Sue et al., 2012), Greenwood et al. (2000)
argued that mentally ill patients do not view stigma as a major issue impacting their
decision to engage in care, and that they often receive sufficient support from family
members to access and continue in mental health care.
Some scholars have suggested that API populations often seek out Eastern
approaches, such as herbal medicine, rather than Western treatment. Greenwood et al.
(2000) argued that, based on the qualitative study they conducted in England, Eastern
medicines are popular among Asian patients, but should not be considered an alternative
to Western treatment because they are ineffective with HIV/AIDS. API patients often use
Eastern medicine as a complement to the Western treatment they are already undergoing
(Greenwood et al., 2000). Zebracki and Drotar (2004) pointed out that although children
and adolescents with high self-efficacy were able to solve problems related to their
asthma treatment and follow through with treatment that was beneficial to them, those
with overly optimistic outcome expectations were likely to have low treatment adherence
and experience worsened asthma symptoms.
Importance of Current Study
A limited selection of literature provides information on API cultures and the
attitudes within the cultures toward HIV/AIDS and psychotherapy (Hall et al., 2011;
Kang et al., 2006; Leong et al., 2011; Miller et al., 2011), And some literature focuses on
the relationship between social support and treatment adherence (including
psychotherapy) among non-API populations. Howver, very few researchers have
explored the relationship between social support and treatment adherence for APIs. Irvine
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et al. (2015) confirmed that the social support that results from access to care
coordination services positively impacts the health outcome of patients with HIV/AIDs.
This study sought to contribute to the under-researched area of the possible
relationship among the factors of social support, psychotherapy attendance rates, and
health outcomes in the vulnerable API population in which the HIV/AIDS infection rate
is increasing and that may have unique sociocultural needs. The study also explores
differences between API and non-API patients. The aim of the study was to discover
whether APIs who have HIV/AIDS and who currently have social support have a higher
rate of participation in psychotherapy along with comparatively better health outcomes in
comparison to non-API populations. In confirming those better outcomes, the study
showed that social services could identify ways of providing APIs with direct, culturally
appropriate social support that increases their psychotherapy attendance and improves
their health outcomes.
In this quantitative study, I focused on how social support influences attendance
rates in psychotherapy and, consequently, health outcomes among API patients diagnosed
with HIV/AIDS in comparison to other groups. I collected and reviewed data pertaining
to patient demographics, diagnosis, adherence to medical and psychotherapy
appointments, and access to social support contained in anonymous medical files of
HIV/AIDS patients at a community health center. Demographic information included
age, household income, gender, sexual orientation, and ethnicity. Three main areas of
research include: (a) the impact of HIV/AIDS status and ethnicity on psychotherapy
adherence rate; (b) the impact of social support on psychotherapy retention rate; and (c)
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the impact of psychotherapy attendance on health outcomes. This quantitative analysis
will help pinpoint whether social support can decrease the dropout rate in psychotherapy
among API HIV/AIDS patients.
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Chapter 3: Research Methodology
Introduction
The purpose of this quantitative causal comparative study was to examine the
psychotherapy attendance rates among API and non-API patients with HIV/AIDS, as
well as API and non-API individuals not diagnosed with HIV/AIDS. I also aimed to
identify the impact of social support on attendance rates and on health outcomes such as
CD4 and viral load.
I employed a quantitative causal comparative design in this study to identify
relationships between identified variables. The independent variables were the population
group membership of participants (a) people who are APIs and who have HIV/AIDS; (b)
APIs who are not diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d)
non-APIs who are not diagnosed with HIV/AIDS. The dependent variables were the
psychotherapy attendance rates, andthe health outcomes of CD4 and viral load. I
collected data from the anonymous medical files of HIV/AIDS patients at a community
health center in New York City. I analyzed the data gathered in this study using
descriptive and inferential statistics in order to determine factors that increase
psychotherapy attendance of APIs who have HIV/AIDS. I sought to address the
following research questions and to test the following hypotheses:
RQ1: What are the differences in psychotherapy attendance rates over a one-year
period among the following groups: (a) API patients who have HIV/AIDS; (b) APIs not
diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d) non-APIs not
diagnosed with HIV/AIDS?
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H01a: Patients not diagnosed with HIV/AIDS have lower psychotherapy
attendance rates over time compared to patients diagnosed with HIV/AIDS.
H11a: Patients diagnosed with HIV/AIDS have higher psychotherapy attendance
rates over time compared to patients not diagnosed with HIV/AIDS.
H01b: APIs have lower psychotherapy attendance rates over time compared to
non-APIs.
H11b: Non-APIs have higher psychotherapy attendance rates over time compared
to APIs.
RQ2: What is the effect of social support (as measured by level of support given
by case workers) on retention in psychotherapy in the following groups: (a) people who
are APIs and who have HIV/AIDS; (b) APIs not diagnosed with HIV/AIDS; (c) nonAPIs who have HIV/AIDS; and (d) non-APIs not diagnosed with HIV/AIDS?
H02 a: Social support, as measured by level of support given by case workers, has
no positive impact on retention in psychotherapy.
H12 a: Social support, as measured by level of support given by case workers, has
a positive impact on retention in psychotherapy.
RQ3: What are the differences in health outcomes, as measured through CD4 and
viral load, in the following groups: (a) people who are APIs and who have HIV/AIDS;
(b) APIs not diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d) nonAPIs not diagnosed with HIV/AIDS?
H03a: Patients not diagnosed with HIV/AIDS have lower health outcomes, as
measured through CD4 and viral load, compared to patients diagnosed with HIV/AIDS.
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H13a: Patients diagnosed with HIV/AIDS have higher health outcomes, measured
through CD4 and viral load, as compared to patients not diagnosed with HIV/AIDS.
H03b: APIs have lower health outcomes, as measured through CD4 and viral load,
compared to non-APIs.
H13b: APIs have higher health outcomes, as measured through CD4 and viral
load, compared to non-APIs.
Research Design and Rationale
I conducted this quantitative non-experimental causal comparative study to
analyze the relationships among the variables of race, social support, and psychotherapy
attendance rates. Among the identified groups, I compared the psychotherapy attendance
rates and health outcomes as measured through CD4 count and viral load, as well as the
relationship of social support with retention in psychotherapy. I employed a quantitative
methodology in this study because the purpose was to explore potential relationships
between variables (Babbie, 2012). A quantitative approach allows the researcher to use
an objective measure of the constructs considered in a study (Bryman, 2012).
Specifically, because I considered the medical condition of patients, I obtained standard
medical measures using numeric values. For this purpose, a quantitative approach was
more appropriate than a qualitative approach.
Furthermore, researchers use a causal comparative research design when aiming
to determine the cause for, or the consequences of, existing differences in groups of
individuals (Norris, Ross, & Schoonen, 2015). Causal comparative research involves
comparing two or more groups to explain existing differences between them on the
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variables of interest, and then explaining the causes of these differences (Hoe & Hoare,
2012). In order to establish causality, the cause must proclaim its effect, or at least the
direction of influence should be from cause to effect. Alternatively, changes in the causal
factors, or independent variables, must influence changes in the effects, or dependent
variables, but not vice versa (Norris et al., 2015). Because the purpose of this study was
to examine not only the relationships but also the differences between the four different
groups, this research method was appropriate.
A qualitative design was not appropriate, because a qualitative study gathers data
that is textual in nature and used to identify and analyze themes describing the
experiences of the participants, with whom the researcher is not personally involved
(Smeyers, 2008). In qualitative methods, causality cannot be determined, and therefore,
qualitative studies are exploratory and open-ended in nature (Johnson et al., 2003).
Although I do not seek to identify causality between variables in this current study, I did
not choose a qualitative method because the focus was not to identify variables openendedly. My focus was on identifying relationships between variables, but qualitative
methods are best to establish themes based on the lived experiences of participants
(Brewer & Kuhn, 2010). Moreover, a qualitative study is focused on answering how and
why questions, which provide subjective results based on the responses of interviewees.
Quantitative research is appropriate for measuring specific outcomes and theories,
in that it involves formulating hypotheses, counting and measuring the outcome data, and
using statistical analysis to obtain and verify a numeric set of data (Babbie, 2012). A
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quantitative approach allows for an objective measure of the variables considered in the
study in order to test the potential relationships between such variables statistically.
Methodology
In this section, I discuss the target population, sampling plan techniques, and
sample size calculation used in this study.
Population
The target population in this study was people living in the United States who are
APIs and who have HIV/AIDS, and people living in the United States who are non-APIs
and have HIV/AIDS. The population of APIs makes up less than 5% of the total U.S.
population (CDC, 2015). In 2013, about 973 APIs in the United States were diagnosed
with HIV/AIDS, of which 82% (n = 799) were males and 16% (n = 159) were females
(CDC, 2015). I drew the sample for this study from a New York City community health
center that provides medical treatment for API and non-API populations and served more
than 2,000 clients in 2014.
Sampling and Sampling Procedures
I used secondary data in this study; therefore, it was possible to obtain all data
points needed for this study. To ensure that sufficient data was gathered for the study, I
calculated the minimum sample size through a power analysis. A power analysis
considers the standard of 80% power to achieve statistical validity (Faul, Erdfelder,
Buchner, & Lang, 2013). Statistical power refers to the likelihood of detecting, within a
sample, a relationship that exists within the population (Cohn & Becker, 2003).
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I considered several other factors such as effect size, statistical test, and
significance level for this calculation. Typically, a medium effect size (denoted by f) is
advisable for quantitative studies because it occupies the middle ground between being
too strict and too lenient in determining the significance of relationship between variables
(Berger, Bayarri, & Pericchi, 2013). I considered a medium effect size of 0.25, factorial
ANOVA with at least four groups, and a significance level of .05. Based on these factors,
at least 158 participants were necessary to achieve a power of 80%. Thus, I gathered 193
participants and considered all 193 patients as study participants.
Procedures for Recruitment, Participation, and Data Collection
The primary data sources were de-identified electronic medical records from the
community health clinic. The clinic provides primary medical care to adults 18 and over,
including specialty care and mental health treatment for HIV/AIDS patients in both API
and non-API populations. The information in the records included (a) frequency of
accessing medical care, (b) frequency of accessing psychotherapy, (c) age, (d) household
income, (e) gender, (f) sexual orientation, (g) HIV status, (h) race, and (i) level of social
support (case workers). I gathered the information from individual, de-identified records
on a per-patient basis.
A goal of data collection was to avoid the exploitation of this potentially
vulnerable population. Therefore, I did not interview or speak directly with API patients
with HIV/AIDS. To protect the patients’ confidential information and identities, I used
subject identification numbers as identifiers rather than names (such as P01 for
Participant 1). I was granted access to data from the administrators of the participating
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community health center in New York City, and my study was approved by Walden
University’s Institutional Review Board (IRB). The initial priority in this study was to
gain approval from the IRB for a data usage agreement, so I sought met the requirements
for IRB for approval from the data source. I signed a non-disclosure agreement to ensure
that the data gathered from the community health centers was only used for the purpose
of this study. After collecting all relevant data from the individual records of each patient,
I input the data and prepared it for analysis in SPSS v21.0.
Operationalization of Constructs
Demographic Characteristics
I collected the demographic information of participants from their individual
medical records. The demographic information included the following: (a) age; (b)
household income; (c) gender; (d) sexual orientation; (e) HIV status; and (f) race. I
considered these variables to be categorical in nature, and I input them based on
identified numerical values. I categorized race as API or non-API, and categorized HIV
status as yes (has HIV/AIDS) or no (does not have HIV/AIDS).
Social Support
In the patients’ medical records, the access to social support is indicated by the
level of support received by the patients from a case worker. I measured patients’ levels
of social support by using the records to identify whether there was a caseworker
attending his or her needs. I considered this as a categorical variable in the data analyses
as either yes (there is a case worker) or no (there is not a case worker).
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Psychotherapy Attendance Rates
I calculated psychotherapy attendance rates based on the number of days the
patient had attended psychotherapy and the total number of days scheduled over a year in
2015. I considered this measure as a continuous variable.
Health Outcomes
I measured the health outcomes of CD4 count and viral load using a standardized
medical test. A normal CD4 cell count in an HIV-negative man is between 400 and 1600
per cubic millimeter of blood, while CD4 cell counts in HIV-negative women tend to be a
little higher, between 500 and 1500. This particular blood test monitors different aspects
of the infected patients, such as CD4, viral load, and resistance. The quantity of virus that
individuals living with HIV have in their blood is referred to as the “viral load.” When a
person has very little of the virus, for example, they have an “undetectable” viral load. I
also considered this construct as a continuous variable. According to the Presidential
AIDS Advisory Panel Report (2001), CD4 count is used to examine the CD4 Tlymphocytes in the patient’s blood. Because CD4 is negatively correlated with viral load,
it is a strong indicator of the effectiveness of anti-retroviral therapy.
Data Analysis Plan
I analyzed the dataset using SPSS v21.0 with an alpha level (α) of 0.05 to
determine significance levels. I used factorial ANOVA to test the first set of hypotheses,
which aims to determine the differences in psychotherapy attendance rates over time
among the following groups: (a) people who are APIs and have HIV/AIDS, (b) APIs not
diagnosed with HIV/AIDS, (c) non-APIs who have HIV/AIDS, and (d) non-APIs not
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diagnosed with HIV/AIDS (George & Mallery, 2014). Similarly, I used factorial
ANOVA to test the second set of hypotheses to determine the effect of social support, as
measured by the level of support given by case workers, on retention in psychotherapy
among the same four groups (Gravetter & Wallnau, 2009). Lastly, I used factorial
ANOVA to test the third set of hypotheses to identify the differences in health outcomes,
as measured by CD4 and viral load in these four groups.
Threats to Validity
I used secondary data as the data source of this study, which represents limited
threats to validity. One important consideration in this study was the timeliness of data
gathered. The timeliness of data affects the validity of the study because the results may
already be irrelevant if the data is old. I used the most recent reports of health centers to
the community health center in New York City. In addition, since the data collection was
be done over time, the loss of subjects is inevitable. Thus, final data set may be reduced
and may not exhibit the characteristics of the target population. Moreover, the
information collected from the records may not be complete and may have been collected
in different periods and thus the validity of each data point may be different from the
others. As such, the findings of this study cannot be generalized to a larger population of
API and non-API patients with HIV/AIDS patients.
Ethical Procedures
Although I used secondary data in this study, I considered human participants,
making ethical considerations important factors of the study. To ensure confidentiality
and anonymity of the participants, I omitted from data collection any identifiable
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information such as names and addresses. I also signed a non-disclosure agreement to
ensure that all data gathered in this study was used solely for the purposes of this study.
The approval of the IRB also strengthens the ethical considerations set in this study.
I stored all collected data in a password-protected computer accessible only by
myself. I will safely store all collected data for five years beyond the completion of this
study. Five years following completion of the study, I will destroy and delete all data
with appropriate shredding programs such as Windows File Shredder.
Summary
In this study, I used a quantitative, non-experimental, causal comparative research
design to examine the psychotherapy attendance rates among API HIV/AIDS patients. I
identified the impact of social support on psychotherapy attendance rates and on health
outcomes such as CD4 and viral load. The target population in this study was API
patients with HIV/AIDS living within the United States, and non-API patients with
HIV/AIDS living within the United States. Specifically, the samples were patients at a
community health center in New York City.
I gathered secondary data from the community health center. The independent
variables were the population group membership of participants to (a) people who are
APIs and have HIV/AIDS, (b) APIs not diagnosed with HIV/AIDS, (c) non-APIs who
have HIV/AIDS, and (d) non-APIs not diagnosed with HIV/AIDS. The dependent
variables were the psychotherapy attendance rates as well as health outcomes such as
CD4 and viral load. I analyzed the gathered data through descriptive and inferential
statistics such as factorial ANOVA and repeated measures ANOVA. All data analysis
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considered a significance level of .05. In Chapter 4, I present the results obtained from
the data collection, describing in detail the information obtained and the raw data
collected for this study.
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Chapter 4: Results and Analysis
Introduction
The purpose of this quantitative causal comparative study was to examine the
psychotherapy attendance rates among APIs and non-API who have HIV/AIDS and APIs
and non-APIs not diagnosed with HIV/AIDS, with the goal of identifying the impact of
social support on attendance rates and on health outcomes such as CD4 and viral load.
Chapter 4 includes the results of my data analysis using descriptive statistics and factorial
ANOVA. I uased IBM SPSS Statistics Version 22 to conduct the data analysis. I
developed the following research questions and hypotheses to guide this study:
RQ1: What are the differences in psychotherapy attendance rates over a one-year
period among the following groups: (a) people who are APIs and have HIV/AIDS
patients; (b) APIs not diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and
(d) non-APIs not diagnosed with HIV/AIDS?
H01a: Patients not diagnosed with HIV/AIDS have lower psychotherapy
attendance rates over time compared to patients diagnosed with HIV/AIDS.
H11a: Patients diagnosed with HIV/AIDS have higher psychotherapy attendance
rates over time compared to patients not diagnosed with HIV/AIDS.
H01b: APIs have lower psychotherapy attendance rates over time compared to
non-APIs.
H11b: Non-APIs have higher psychotherapy attendance rates over time compared
to APIs.
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RQ2: What is the effect of social support (as measured by level of support given
by case workers) on retention in psychotherapy in the following groups: (a) people who
are APIs and have HIV/AIDS; (b) APIs not diagnosed with HIV/AIDS; (c) non-APIs
who have HIV/AIDS; and (d) non-APIs not diagnosed with HIV/AIDS?
H02 a: Social support, as measured by level of support given by case workers, has
no positive impact on retention in psychotherapy.
H12 a: Social support, as measured by level of support given by case workers, has
a positive impact on retention in psychotherapy.
RQ3: What are the differences in health outcomes, as measured through CD4 and
viral load, in the following groups: (a) people who are APIs and have HIV/AIDS; (b)
APIs not diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d) nonAPIs not diagnosed with HIV/AIDS?
H03a: Patients not diagnosed with HIV/AIDS have lower health outcomes, as
measured through CD4 and viral load, compared to patients diagnosed with HIV/AIDS.
H13a: Patients diagnosed with HIV/AIDS have higher health outcomes, measured
through CD4 and viral load, as compared to patients not diagnosed with HIV/AIDS.
H03b: APIs have lower health outcomes, as measured through CD4 and viral load,
compared to non-APIs.
H13b: APIs have higher health outcomes, as measured through CD4 and viral
load, compared to non-APIs.
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Demographic Information of the Sample
In Table 1 below, I show the demographic profile of sample subjects included in
the study. I obtained the demographic information from individual medical records. The
demographic information I gathered included the following: (a) age, (b) household
income, (c) gender, (d) sexual orientation, (e) HIV status, and (f) race. The realized
sample size was 993, representing API and non-API patients with HIV/AIDS, and API
and non-API subjects who were HIV negative, and all of whom had scheduled mental
health appointments.
Gender was divided as follows among the 993 study participants: 500 of them
(50.4%) were male, 139 of them (14.0%) were female, 190 of them (19.1%) were
transgender identifying as female, and 118 of them (11.9%) were transgender identifying
as male. Participants ranged in age from 18 to 45 years old. In terms of age, 417 of the
993 study participants (42%) were between 25 and 34 years old. For sexual orientation,
409 of the 993 participants (41.2%) were gay. The majority of the participants (795 of
them, or 76%) were non-API. For income range, 540 participants (54.4%) had income
less than 100% of federal poverty level. A total of 609 participants (61.3%) had stable
housing status. In terms of HIV status, 359 participants (36.2%) were HIV positive, and
277 of the participants (27.9%) had viral load suppressed. Almost all participants (989 of
them, or 99.6%) had other illnesses. A majority of the 993 participants (736 of them, or
74.1%) had mental health diagnoses. Lastly, more than half of the participants (568 of
them; or 57.2%) had social support from case workers.
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Table 1. Frequency and Percentage Summaries of Demographic Information (N=993)
Frequency
Age range
18-24
25-34
35-44
45+
Gender
Female
Male
Transgender identifying as female
Transgender identifying as male
GQ
Sexual orientation
Straight or heterosexual
Gay
Lesbian
Queer
Bisexual
Other
Choose not to disclose
Missing
Race group
Non-API
API
Income range
Less than 100%
101-200%
201-300%
Greater than 301%
Housing status
Contradicting
Homeless
Public
Stable
Unknown

Percent

139
417
214
223

14.0
42.0
21.6
22.5

139
500
190
118
46

14.0
50.4
19.1
11.9
4.6

203
409
45
189
91
53
2
1

20.4
41.2
4.5
19.0
9.2
5.3
0.2
0.1

795
198

80.1
19.9

540
186
101
142

54.4
18.7
10.2
14.3

92
113
18
609
160

9.3
11.4
1.8
61.3
16.1

(Continued	
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Frequency

Percent

1

0.1

634
359

63.8
36.2

716
277

72.1
27.9

4
989

0.4
99.6

257
736

25.9
74.1

993

100.0

425
568

42.8
57.2

Housing status (cont’d)
Missing
HIV status
Negative
Positive
Viral Load suppressed
No
Yes
Has other illness
No
Yes
Mental health diagnosis
No
Yes
Scheduled mental health appointment
Yes
Social support (has case worker)
No
Yes
Summary of Study Outcome Variables

Table 2 shows the psychotherapy attendance and health outcomes of CD4 count
and viral load from a standardized medical test. For psychotherapy attendance, 993 out of
the 993 samples had this data. The mean of psychotherapy appointments kept was 2.28
(SD = 2.21). The possible range of values for psychotherapy attendance was 1 to 15
appointments. This dependent variable had a positively skewed distribution (see
histogram in Figure 1). Only 143 f the 993 participants had CD4 count data. The mean
CD4 count was 641.85 (SD = 277.70). The possible range of values for CD4 count was
68 to 1,871. CD4 had a fairly symmetrical distribution indicating no large departure from
normal distribution (see histogram in Figure 2). For the viral load data, values ranged
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from 1 to 825,234. The mean viral load was 8,587 (SD = 54,343.53). There were 153
(15.4%) of the participants who had a viral load of greater than 20 and not detected, while
56 of the participants (5.6%) had a viral load of greater than 20 and detected, and 31 of
the participants (3.1%) had a viral load of greater than 20. Last viral load has a positively
skewed distribution.
Table 2. Descriptive Statistics Summaries of Values for Psychotherapy CD4 Counts, and
Viral Load (N=993)
N

Minimum

Maximum

Mean

Std. deviation

Psychotherapy attendance
rates (# of mental health
appointments kept)

993

1

15

2.28

2.21

Last CD4

143

68

1871

641.85

277.70

Last viral load

336

1

825234

8587.00

54343.53

Figure 1. Histogram of Number of Mental Health Appointments
Kept
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Figure 2. Histogram of Last CD4

Figure 3. Histogram of Last Viral Load
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Factorial ANOVA Results for RQ1
RQ1 and the associated hypotheses are presented below, followed by results of
the associated statistical analyses.
RQ1: What are the differences in psychotherapy attendance rates over the period
of a year among the following groups: (a) people who are APIs and have HIV/AIDS, (b)
APIs not diagnosed with HIV/AIDS, (c) non-APIs who have HIV/AIDS, and (d) nonAPIs not diagnosed with HIV/AIDS?
H01a: Patients not diagnosed with HIV/AIDS have lower psychotherapy
attendance rates over time compared to patients diagnosed with HIV/AIDS.
H11a: Patients diagnosed with HIV/AIDS have higher psychotherapy attendance
rates over time compared to patients not diagnosed with HIV/AIDS.
H01b: APIs have lower psychotherapy attendance rates over time compared to
non-APIs.
H11b: Non-APIs have higher psychotherapy attendance rates over time compared
to APIs.
I conducted a factorial ANOVA to answer RQ1. The independent variables were
the population of participants by race and HIV status. The dependent variable was
psychotherapy attendance rates. The factorial ANOVA included the main effects of race
and HIV status, and also the interaction effects of race and HIV status on the
psychotherapy attendance rates. Table 3 shows the factorial ANOVA results in terms of
the between-subjects effects.
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The results of the factorial ANOVA showed that psychotherapy attendance rates
were not significantly different across race differences [F(1, 993) = 1.28, p = 0.26] and
HIV status [F(1, 993) = 0.00, p = 0.96]. These were because the p-values were lower
than the level of significance value of 0.05. This means that the psychotherapy attendance
rates were not significantly different between those diagnosed with HIV/AIDS and those
who were not diagnosed with HIV/AIDS. HIV status did not affect psychotherapy
attendance rate. Also, the psychotherapy attendance rates were not significantly different
between API and non-API participants. The interaction effect of race and HIV status on
psychotherapy attendance rates [F(1, 993) = 0.39, p = 0.53] was not significant. This
means that the psychotherapy attendance rates were not significantly different among the
following groups: (a) people who are APIs and have HIV/AIDS, (b) APIs not diagnosed
with HIV/AIDS, (c) non-APIs who have HIV/AIDS, and (d) non-APIs not diagnosed
with HIV/AIDS. This indicates that after adjusting for differences in race groups, there is
no significant difference in psychotherapy attendance rates between HIV positive and
HIV negative subjects. I did not perform post hoc tests because the independent variables
of race and HIV status had no significant relationship with psychotherapy attendance
rates. With this result, the null hypothesis for RQ1 that “Patients not diagnosed with
HIV/AIDS have lower psychotherapy attendance rates over time compared to patients
diagnosed with HIV/AIDS” was not rejected based on the results of the factorial
ANOVA.
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Table 3. Tests of Between-Subject Effects of Race and HIV Status on Psychotherapy
Attendance Rates (N=993)
Type III
Mean
Source
sum of
df
F
square
squares
Corrected Model
10.51
3
3.50
0.72
Intercept
2999.25
1
2999.25
616.47
Race group
6.25
1
6.25
1.28
HIV status
0.01
1
0.01
0.00
Race group * HIV status
1.92
1
1.92
0.39
Error
4811.66
989
4.87
Total
9984.00
993
Corrected total
4822.17
992
Note. R squared = 0.002 (adjusted R squared = -0.001); dependent variable:
psychotherapy attendance rates (number of mental health appointments kept)

Sig.

Table 4. Descriptive Statistics Results of Psychotherapy Attendance Rates by Race and
HIV Status (N=993)
Race group
Non-API

HIV status
Negative
Positive
Total

Mean
2.36
2.26
2.32

Std. deviation
2.26
2.23
2.25

N
526
269
795

API

Negative
Positive
Total

2.05
2.17
2.10

1.87
2.15
2.00

108
90
198

Total

Negative
Positive
Total

2.31
2.23
2.28

2.20
2.21
2.21

634
359
993

Factorial ANOVA Results for RQ2
RQ2 and the associated hypotheses are presented below. This is followed by the
results of the statistical analysis I performed.
RQ2: What is the effect of social support, as measured by level of support given
by case workers, on retention in psychotherapy in the following groups: (a) API patients
	
  

0.54
0.00
0.26
0.96
0.53
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with HIV/AIDS; (b) APIs not diagnosed with HIV/AIDS; (c) non-API patients who have
HIV/AIDS; and (d) non-APIs not diagnosed with HIV/AIDS?
H02 a: Social support, as measured by level of support given by case workers, has
no positive impact on retention in psychotherapy.
H12 a: Social support, as measured by level of support given by case workers, has
a positive impact on retention in psychotherapy.
A factorial ANOVA was conducted to address RQ2. The independent variables
were the population of participants by social support (or the level of support given by
caseworkers), race, and HIV status. The dependent variable was psychotherapy
attendance rates. The factorial ANOVA included the main effects of social support, race,
and HIV status, and also the interaction effects of social support, race, and HIV status, on
the psychotherapy attendance rates. Table 5 presents the factorial ANOVA results in
terms of the between-subject effects.
The results of the factorial ANOVA showed that psychotherapy attendance rates
were not significantly different across differences of the participants’ social support [F(1,
993) = 0.38, p = 0.54]. This means that the psychotherapy attendance rates were not
significantly different between those that had social support from caseworkers and those
that did not. Support status does not show significant effect on psychotherapy attendance
rate. In addition, the interaction effects of social support and HIV status (F (1, 993) =
0.73, p = 0.39]) and the interaction effects of social support and race [F (1, 993) = 0.49, p
= 0.48] on psychotherapy attendance rates were not significant. This means that the
psychotherapy attendance rates were not significantly different among the following
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groups: (a) HIV/AIDS patients with social support, (b) HIV/AIDS patients without social
support, (c) patients not diagnosed with HIV/AIDS and with social support, and (d)
patients not diagnosed with HIV/AIDS and without social support; and also were not
significantly different among the following groups: (a) APIs with social support, (b) nonAPIs without social support, (c) APIs with social support, and (d) non-APIs without
social support.
Lastly, the three-way interaction effect of social support, race, and HIV status on
psychotherapy attendance rates [F (2, 993) = 0.46, p = 0.63] was not significant. This
means that the psychotherapy attendance rates were not significantly different among
differences of social support or among the following groups: (a) people who are APIs and
have HIV/AIDS, (b) APIs not diagnosed with HIV/AIDS, (c) non-APIs who have
HIV/AIDS, and (d) non-APIs not diagnosed with HIV/AIDS. I did not perform post hoc
tests since all the independent variables of social support, race, and HIV status did not
have significant relationships with psychotherapy attendance rates. Instead, I conducted
descriptive statistics analysis. With this result, the null hypothesis for RQ2 that “Social
support, as measured by level of support given by case workers, has no positive impact
on retention in psychotherapy” was not rejected based on the results of the factorial
ANOVA.
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Table 5. Tests of Between-Subject Effects of Social Support, Race and HIV Status on
Psychotherapy Attendance Rates (N=993)
Type III sum
of squares
17.89a

Source
Corrected model
Intercept

df
7

Mean
square
2.56

F
0.52

2937.53 602.27

Sig.
0.82

2937.53

1

0.00

Social support

1.83

1

1.83

0.38

0.54

Race group

5.19

1

5.19

1.06

0.30

HIV status

0.02

1

0.02

0.00

0.95

Social support* HIV status

3.58

1

3.58

0.73

0.39

Social support * Race group

2.40

1

2.40

0.49

0.48

Social support * face group * HIV status

4.50

2

2.25

0.46

0.63

Error

4804.29

985

4.88

Total

9984.00

993

Corrected tTotal

4822.17

992

Note. R squared = 0.004 (adjusted R squared = -0.003); dependent variable: psychotherapy attendance
rates (number of mental health appointments kept)

Table 6. Descriptive Statistics Results of Psychotherapy Attendance Rates by Social
Support, Race, and HIV Status (N=993)
Social support
(has case worker)
No

Race group
Non-API

API

Total

HIV status
Negative
Positive
Total
Negative
Positive
Total
Negative
Positive
Total

Mean
2.36
2.23
2.32
2.34
2.14
2.25
2.36
2.21
2.31

Std. deviation
2.22
2.20
2.21
2.25
2.13
2.19
2.22
2.17
2.20
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222
120
342
47
36
83
269
156
425

73	
  

Social support
(has case worker)
Yes

Race group
Non-API

API

Total

Total

Non-API

API

Total

HIV status
Negative
Positive
Total
Negative
Positive
Total
Negative
Positive
Total
Negative
Positive
Total
Negative
Positive
Total
Negative
Positive
Total

Mean
2.36
2.28
2.33
1.82
2.19
1.99
2.27
2.25
2.26
2.36
2.26
2.32
2.05
2.17
2.10
2.31
2.23
2.28

Std. deviation
2.30
2.27
2.29
1.50
2.18
1.85
2.19
2.24
2.21
2.26
2.23
2.25
1.87
2.15
2.00
2.20
2.21
2.21

	
  

Factorial ANOVA Results for RQ3
RQ3 and the associated hypotheses are presented below. This is followed by
results of statistical analysis performed.
RQ3: What are the differences in health outcomes, as measured through CD4 and
viral load, in the following groups: (a) API patients who have HIV/AIDS, (b) APIs not
diagnosed with HIV/AIDS, (c) non-API patients who have HIV/AIDS, and (d) non-APIs
not diagnosed with HIV/AIDS?
H03a: Patients not diagnosed with HIV/AIDS have lower health outcomes, as
measured through CD4 and viral load, compared to patients diagnosed with HIV/AIDS.
	
  

N
304
149
453
61
54
115
365
203
568
526
269
795
108
90
198
634
359
993
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H13a: Patients diagnosed with HIV/AIDS have higher health outcomes, measured
through CD4 and viral load, as compared to patients not diagnosed with HIV/AIDS.
H03b: APIs have lower health outcomes, as measured through CD4 and viral load,
compared to non-APIs.
H13b: APIs have higher health outcomes, as measured through CD4 and viral
load, compared to non-APIs.
I conducted a factorial ANOVA to address RQ3. The independent variables were
the population group participants by race and HIV status. The dependent variables were
health outcomes of CD4 and viral load. The factorial ANOVA included the main effects
of race and HIV status and also the interaction effects of race and HIV status on health
outcomes. Two different factorial ANOVAs were conducted for each of the health
outcomes.
First, Table 7 presents the factorial ANOVA results in terms of the betweensubjects effects on the dependent variable of health outcomes of CD4 counts. The results
of the factorial ANOVA showed that CD4 counts were significantly different across
differences of race [F (1, 143) = 5.27, p = 0.02]. This was because the p-value was lower
than the level of significance value of 0.05. This means that the CD4 counts were
significantly different between API and non-API participants. I did not perform post hoc
tests since the independent variable of race had fewer than three categorical groups.
Instead, I conducted a mean comparison.
As can be seen in the descriptive statistics in Table 8, the CD4 counts of non-APIs
(M = 674.03; SD = 288.61) was significantly greater than the CD4 counts APIs (M =
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556.03; SD = 228.04). Also, the individual effect of HIV status and the interaction effect
of race and HIV status on CD4 counts were not significant. This means that the CD4
counts were not significantly different among the following groups: (a) people who are
APIs and have HIV/AIDS, (b) APIs not diagnosed with HIV/AIDS, (c) non-APIs who
have HIV/AIDS, and (d) non-APIs not diagnosed with HIV/AIDS.
Table 7. Tests of Between-Subject Effects of Race and HIV Status on Health Outcomes of
CD4 Counts (N=143)
Source
Corrected model
Intercept
Race group
HIV status
Race group * HIV status
Error
Total
Corrected total

Type III
sum of squares
394956.728a
42915147.36
394956.73
0.00
0.00
10555267.89
69861432.00
10950224.62

Df
1
1
1
0
0
141
143
142

Mean square
394956.73
42915147.36
394956.73
.
.
74860.06

F
5.28
573.27
5.28
.
.

Note. * Significant at level of significance of 0.0g; R squared = 0.04 (adjusted R squared = 0.03);
dependent variable: last CD4.

Table 8. Descriptive Statistics Results of CD4 Counts by Race and HIV Status (N = 143)
Race group
Non-API
API
Total

HIV status
Positive
Total
Positive
Total
Positive
Total

Mean
Std. deviation
674.03
288.61
674.03
288.61
556.03
228.04
556.03
228.04
641.85
277.70
641.85
277.70

N
104
104
39
39
143
143

The CD4 variable showed no valid observations for HIV-negative cases, which
means that a test for significance of difference in the CD4 variable across HIV status
	
  

Sig.
0.02*
0.00*
0.02*
.
.

76	
  

cannot be performed. Therefore, only comparison of viral load is done across HIV status
categories using independent samples t-test. This is appropriate as positive and negative
cases groups are independent, and the CD4 variable is continuous, with a symmetric
distribution that doesn’t significantly depart from normality. Also, sample size is large, so
using the result of central limit theorem, the sampling distribution of the test statistic will
be normal.
Table 9 below shows descriptive statistics for the CD4 variable across race groups
along with associated t-test results. The API group had a mean CD 4 of 556.03 (SD =
228.04) while the non-API group had a mean CD4 of 674.03 (SD = 288.61). Results of
Levene’s test shows evidence for equality of variance assumption (F = 2.57, p = 0.11).
Results of independent samples t-test indicates that null hypotheses of no significant
difference in two groups must be rejected at 0.05 level of significance [t(141) = 2.30, p =
0.02]. Specifically, the API group had significantly lower mean CD4 compared to the
non-API group.
Table 9. Comparison of CD4 Between API and Non-API Groups
Race group
Non-API
API

N
104

Mean
674.03

Std. deviation
288.61

39

556.03

228.04

T
2.30

p
0.02*

Note. *Significant at level of significance of 0.05

Table 10 presents the factorial ANOVA results in terms of the between-subject
effects on the dependent variable of the health outcome of viral load. The results of the
factorial ANOVA showed that viral load was not significantly different across race
differences [F(1, 336) = 0.08, p = 0.78] and HIV status [F(1, 336) = 0.15, p = 0.70]).
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These were because the p-values were greater than the level of significance value of 0.05.
This means that viral loads were not significantly different between those diagnosed with
HIV/AIDS and those who were not diagnosed with HIV/AIDS; and between APIs and
non-APIs. Also, the interaction effect of race and HIV status on viral load [F(1, 336) =
0.08, p = 0.78] was not significant. This means that viral load was not significantly
different among the following groups: (a) API patients who have HIV/AIDS, (b) APIs
not diagnosed with HIV/AIDS, (c) non-API patients who have HIV/AIDS, and (d) nonAPIs not diagnosed with HIV/AIDS. With the results of these factorial ANOVAs, the
null hypothesis for RQ3a that “Patients not diagnosed with HIV/AIDS has lower health
outcomes, as measured through CD4 and viral load, compared to patients diagnosed with
HIV/AIDS” and null hypothesis for RQ3b that “APIs have lower health outcomes, as
measured through CD4 and viral load, compared to non-APIs” were not rejected based on
the results of the factorial ANOVA for CD4 counts.
Table 10. Tests of Between-Subject Effects of Race and HIV Status on Health Outcomes
of Viral Load (N = 336)
Source
Corrected model
Intercept
Race group
HIV status
Race group * HIV status
Error
Total
Corrected total

Type III
sum of squares
6567391752.411
436702643.65
235752595.71
435901270.71
235752595.71
982760933655.59
1014103812592.00
989328325408.00

df
3
1
1
1
1
332
336
335

Mean square
2189130584.14
436702643.65
235752595.71
435901270.71
235752595.71
2960123294.14

Note. R squared = 0.01 (adjusted R squared = 0.002); dependent variable: last viral load.

	
  

F
0.74
0.15
0.08
0.15
0.08

Sig.
0.53
0.70
0.78
0.70
0.78
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Since the distribution of viral load is extremely skewed, comparison of viral load
distribution between HIV-positive and HIV-negative groups and between API and nonAPI groups is done using a non-parametric test for independent samples. The Mann
Whitney U test is used to test the difference in viral load distribution between two groups.
Table 11 below summarizes results of comparison of viral load distribution across
categories of HIV status and race group. There was significant difference in viral load
across race groups (U = 9035, Z = -2.33, p = 0.02). APIs had higher viral load outcome
compared to non-APIs. There was no significant difference in viral load distribution
between HIV-positive and HIV-negative subjects (U = 1890, Z = -0.17, p = 0.86).
Table 11. Comparison of Viral Load Across HIV Status and Race Groups
Group
Race

Non-API

HIV status

N Mean rank
250
175.36

API

86

Total

336

Sum
of ranks
43840.00

148.56

12776.00

Negative

12

164

1968.00

Positive

324

168.67

54648.0

Total

336

Mann
Whitney U
9035

Z
-2.33

p
0.02*

1890

-0.17

0.86

Note. *Significant at level of significance of 0.05

Summary
The purpose of this quantitative causal comparative study is to examine the
psychotherapy attendance rates among APIs and non-APIs who have HIV/AIDS, and
APIs and non-APIs not diagnosed with HIV/AIDS, and to identify the impact of social
support on attendance rates and, further, on health outcomes such as CD4 and viral load.
	
  

79	
  

This chapter presented the results and analysis of the factorial ANOVAs to address the
research questions of the study.
•

For RQ1, the factorial ANOVA results showed that patients diagnosed with
HIV/AIDS do not have higher psychotherapy attendance rates over time
compared to patients not diagnosed with HIV/AIDS; and non-APIs have
higher psychotherapy attendance rates over time compared to APIs.

•

For RQ2, the factorial ANOVA results showed that social support, as
measured by level of support given by case workers, has no significant impact
on retention in psychotherapy. CD4 counts for non-APIs were significantly
greater than the CD4 counts for APIs. Independent sample t-test also showed
that the API group had a significantly lower mean CD4 compared to the nonAPI group.

•

For RQ3, the factorial ANOVA results showed that health outcomes, as
measured through CD4 count, was significantly different across differences of
race. CD4 counts of those non-APIs were significantly greater than the CD4
counts of APIs. However, CD4 count was not significantly different across
differences of HIV status, and Mann Whitney U test results showed that APIs
had higher viral load outcome compared to non-APIs.

Chapter 5 includes further discussion of the results presented in this chapter. Each of
the results in each of the research questions was reviewed and the potential implications
for each of the results is presented.
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Chapter 5: Discussion and Recommendation
Introduction
The objective of this quantitative causal comparative study was to understand the
relationships among psychotherapy attendance rates, social support to attendance rates
and health outcomes such as CD4 and viral load, among API and non-API patients with
HIV/AIDS. I used factorial ANOVA, descriptive analysis, and regression analysis to
analyze the historical medical data of patients of a community health center in New York
City. I used IBM SPSS Statistics Version 22 to conduct the data analysis.
I developed the following research questions and associated hypotheses for the
study:
RQ1: What are the differences in psychotherapy attendance rates over a one-year
period among the following groups: (a) API patients who have HIV/AIDS; (b) APIs not
diagnosed with HIV/AIDS; (c) non-API patients who have HIV/AIDS; and (d) non-APIs
not diagnosed with HIV/AIDS?
H01a: Patients not diagnosed with HIV/AIDS have lower psychotherapy
attendance rates over time compared to patients diagnosed with HIV/AIDS.
H11a: Patients diagnosed with HIV/AIDS have higher psychotherapy attendance
rates over time compared to patients not diagnosed with HIV/AIDS.
H01b: APIs have lower psychotherapy attendance rates over time compared to
non-APIs.
H11b: Non-APIs have higher psychotherapy attendance rates over time compared
to APIs.
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RQ2: What is the effect of social support (as measured by level of support given
by case workers) on retention in psychotherapy in the following groups: (a) API patients
who have HIV/AIDS; (b) APIs not diagnosed with HIV/AIDS; (c) non-API patients who
have HIV/AIDS; and (d) non-APIs not diagnosed with HIV/AIDS?
H02 a: Social support, as measured by level of support given by case workers, has
no positive impact on retention in psychotherapy.
H12 a: Social support, as measured by level of support given by case workers, has
a positive impact on retention in psychotherapy.
RQ3: What are the differences in health outcomes, as measured through CD4 and
viral load, in the following groups: (a) people who are APIs and who have HIV/AIDS;
(b) APIs not diagnosed with HIV/AIDS; (c) non-APIs who have HIV/AIDS; and (d) nonAPIs not diagnosed with HIV/AIDS?
H03a: Patients not diagnosed with HIV/AIDS have lower health outcomes, as
measured through CD4 and viral load, compared to patients diagnosed with HIV/AIDS.
H13a: Patients diagnosed with HIV/AIDS have higher health outcomes, measured
through CD4 and viral load, as compared to patients not diagnosed with HIV/AIDS.
H03b: APIs have lower health outcomes, as measured through CD4 and viral load,
compared to non-APIs.
H13b: APIs have higher health outcomes, as measured through CD4 and viral
load, compared to non-APIs.
The results of the study showed the relationships among psychotherapy
attendance rates, social support, and health outcomes for API and non-API patients with
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HIV/AIDS. The following results showed statistically non-significant relationships: (a)
patients diagnosed with HIV/AIDS do not have higher psychotherapy attendance rates
over time compared to patients not diagnosed with HIV/AIDS, and non-APIs have higher
psychotherapy attendance rates over time compared to APIs; (b) social support, as
measured by level of support given by case workers, has no significant impact on
retention in psychotherapy; and (c) health outcomes, as measured through CD4 count,
was not significantly different across differences of race. These results indicate that the
hypothesized significant impact of social support on psychotherapy attendance rates, as
well as on health outcomes such as CD4 and viral load, for APIs and non-APIs who have
HIV/AIDS cannot be generalized. That is, any reported difference in attendance rate or
health outcomes is essentially attributed to chance owing to sampling.
This study is important for practitioners’ understanding of the how APIs
diagnosed with HIV/AIDS seek and respond to health care. The study contributes to the
current body of literature on APIs and mental health by augmenting the understanding of
API behaviors, with regards to mental healthcare. In addition, thes study offers
significant insights for researchers and mental health care providers on the different
factors that affect the behaviors of APIs.
Chapter 5 begins with a discussion of the results of the study in light of the
literature presented in the previous chapters. In addition, I discuss the implications of the
results and also identify the study’s limitations. Finally, I offer recommendations for
future studies.
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Psychotherapy Attendance Rates Among API and Non-API Patients
I developed RQ1 to explore the differences in psychotherapy attendance rates
among the following groups: (a) API patients who have HIV/AIDS, (b) APIs not
diagnosed with HIV/AIDS, (c) non-API patients who have HIV/AIDS, and (d) non-APIs
not diagnosed with HIV/AIDS. Specifically, I hypothesized that those who were
diagnosed with HIV/AIDS have higher psychotherapy attendance rates than patients who
were not diagnosed with HIV/AIDS. In addition, I expected non-API patients to have
higher attendance rates over time than API patients.
The results of the analyses for RQ1 showed that there is no significant difference
between API patients and non-API patients with regard to their attendance rates.
However, based on the descriptive statistics, the samples size of non-API patients (N =
2263, 76%) was almost 3.1 times more than the sample size of API patients (N = 993,
24%), which showed the unequal distribution of the groups. Moreover, the mean
difference showed that API patients had lower attendance rates than non-APIs, albeit not
significantly lower. These results clearly indicate that the size or magnitude of the
difference in mean attendance rates is not high enough to provide statistically significant
results. There the difference in mean attendance rates is attributed to chance or sampling
error.
Because of closed communication within the API community, APIs sometimes do
not disclose mental illnesses or seek medical or psychological treatment (Kang et al.,
2006). Unfortunately, researchers have found that this is a major factor for the high
occurrence of depression and other psychological consequences among APIs (Kang et al.,
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2006). Kim et al. (2007) found that the discontinuation of medication is prevalent among
those who have an alcohol problem, and also among those with depressive symptoms but
without substance abuse. Another study showed that patient uncertainty regarding the
effectiveness of medication is one of the reasons for inconsistent medication use (Locher,
Wayson, Pargament, & Duggan, 2007). There were incongruences between the results of
my study and the current literature, which warrant further exploration.
In summary, it is apparent that the main difference in attendance rates is affected
by several factors other than the study variables. Adjusting for the effect of these
variables could more precisely show differences in attendance rates attributed to study
variables. Therefore, I recommend that subsequent researchers explore additional factors
that may account for the differences in psychotherapy attendance rates..
Social Support among API and non-API Patients
With RQ2, I examined the effect of social support -- as measured by the level of
support given by case workers -- on psychotherapy retention for the following groups: (a)
API patients who have HIV/AIDS, (b) APIs not diagnosed with HIV/AIDS, (c) non-APIs
who have HIV/AIDS, and (d) non-APIs not diagnosed with HIV/AIDS. Using Bandura’s
(1989) SCT, I hypothesized that social support would be associated with psychotherapy
retention. Specifically, I hypothesized that social support would be positively related to
retention in psychotherapy.
The results showed that psychotherapy attendance rates were not significantly
different across the social support categories. Attendance rates were not different between
those who had social support from case workers and those who did not. Psychotherapy
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attendance rates were not significantly different among the following groups: (a)
HIV/AIDS patients with social support, (b) HIV/AIDS patients without social support,
(c) patients not diagnosed with HIV/AIDS and with social support, and (d) patients not
diagnosed with HIV/AIDS without social support. Neither were retention rates
significantly different among the following groups: (a) APIs with social support, (b) nonAPIs with social support, (c) APIs without social support, and (d) non-APIs patients
without social support. Social support is one of the factors that researchers have identified
as leading people to seek and remain in psychotherapy (Irvine et al., 2015; Yeun et al.,
2013). Moreover, social support generally promotes positive health outcomes including
higher treatment adherence rates (Irvine et al., 2015; Mutchler et al., 2011; O’Laughlin et
al., 2012; Westmaas et al., 2010). On this premise, one might presume a link among the
factors of HIV/AIDS diagnosis, social support, psychotherapy attendance, and better
medical outcomes.
The results of this study are incongruent with the notion that social support
increases attendance among API HIV/AIDS patients and decreases dropout rates. One
possible explanation in this discrepancy is the importance of community among API
cultures. API cultures discourage members from seeking mental health care because of
shame and other culture-specific factors. To an extent, this negative outcome reflects the
notion that psychiatric disorders are often a barrier to medical treatment adherence; thus,
researchers have indicated that HIV/AIDS patients who receive psychotherapy have
better health outcomes (Leong et al., 2011). Social support is one of the factors that
researchers have identified as leading people to seek and remain in psychotherapy (Irvine
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et al., 2015; Yeun et al., 2013). In addition, API individuals are highly concerned with
how they are perceived both within the community andwithout (Leong et al., 2011).
Further, this outcome is inconsistent with research focused on social support and
adherence to medical treatment (Mutchler et al., 2011; O’Laughlin et al., 2012; Westmass
et al., 2010). Previous researchers have proven that social support leads to positive
behavioral changes among individuals with chronic diseases (Longo et al., 1992; Shen,
Edwards, Courtney, McDowell, & Wu, 2012). Social support helps increase treatment
adherence or promote positive behavioral changes among the general population, and
receptivity to mental health care is linked to social support (Mutchler et al., 2011;
O’Laughlin et al., 2012; Westmass et al., 2010). However, the outcome of this study
reflects a limit to this link.
The concept of social support as defined in this study may not be what some
patients would consider a close relationship. Research by Tasca (2014) and Yeun et al.
(2013) indicate that feeling close with others is necessary for feeling secure. This study
may not have accounted for a level of closeness with caretakers that would significantly
impact the willingness of patients, both API and non-API alike, to stay in psychotherapy.
Individuals always strive to seek closeness (Tasca, 2014; Yeun et al., 2013), but the level
of intimacy could have been an important determinant on this dynamic. Researchers have
found that strong emotional support and bonds with other individuals and other groups
have positive correlation with high medical adherence (Irvine et al., 2015; Li et al., 2012;
Stubbs et al., 2009; Ushie & Jegede, 2012). I recommend further studies on the impact of
varying levels of closeness, emotional bond, and social support in order to understand the
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complexity of social relationships and their roles in psychotherapy retention and in the
mental health response of individuals, especially APIs.
Another potential reason for the non-significant outcomes of this study is
operationalization of the study’s independent variable. In this study, the independent
variable is taken as the categorical factor of social support. This is operationally defined
as a binary variable with two categories based on whether the patient has an associated
case worker or not. Having an associated case worker directly translates itself into actual
support. Therefore, a more precise measure of quantifying the support as a variable in this
study would be the level of support received. This can potentially direct future research
studies, which should assess whether increases in levels of support are associated with
positive changes in behavior. This study used the proxy binary variable as a “presence”
or “absence” of case worker to operationalize the independent variable, as the historical
data provided limited scope to define this variable. However, this researcher could not
ascertain if the mere “presence” of a case worker equates to support for the patients.
Thus, future researchers should use a more precise measurement of the level of support
that patients receive in order to more effectively analyze the impact of support on
attendance rates and behavior changes.
Health Outcomes among API and non-API patients
RQ3 explored the differences in health outcomes, as measured by CD4 and viral
load, among the following groups: (a) API patients who have HIV/AIDS, (b) APIs not
diagnosed with HIV/AIDS, (c) non-API patients who have HIV/AIDS, and (d) non-APIs
not diagnosed with HIV/AIDS. I hypothesized that patients diagnosed with HIV/AIDS
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would have better health outcomes, measured through CD4 and viral load, as compared
to patients not diagnosed with HIV/AIDS. I also hypothesized that APIs would have
higher health outcomes, as measured through CD4 and viral load, compared to non-APIs.
The results did not show a significant difference in CD4 counts across the groups.
This means that the CD4 counts were not significantly different between those with and
without HIV/AIDS. The CD4 counts of non-API patients diagnosed HIV/AIDS or who
had positive HIV status was not significantly greater than the CD4 counts of API patients
diagnosed with HIV/AIDS or who had positive AID status.
The previous results show a non-significant difference across groups, but it must
be noted that there are more historical cases of non-API patients than API patients
diagnosed with HIV/AIDs. This implies that non-APIs tend to seek treatment more than
APIs. The non-significant difference of CD4 counts between non-APIs and APIs is
consistent with the findings that high CD4 is the likely result of low adherence or nontreatment of chronic illness (Sin & DiMatteo, 2014). This could also lead to other
opportunistic infections and death. Psychological disturbance is harmful to individuals
with HIV -- as Leserman et al. (1999) noted, AIDS progresses more rapidly due to
greater depressive symptoms, more stressful life events, and less social support.
There are many factors that contribute to individuals with HIV seeking medical
care or avoiding treatment (Oppenheimer, 2008). These are often affected by the
emotional problems of the individuals, as well as the substances that they use. TurnerCobb et al. (2002) found that individuals who are well-adjusted to chronic illness such as
HIV/AIDs are those who do not deny their illness and decide instead to cope with it and
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with the stressors that attend the diagnosis. Emotional distress is a factor identified as a
significant predictor of disease progression by Vedhara, Nott, Bradbeer and Davidson
(1997). I expected that APIs diagnosed with HIV/AIDS would have higher CD4 counts,
but I actually found that non-APIs with HIV/AIDS had significantly higher CD4 counts.
This outcome is theoretically inconsistent with the notion that having a major
depressive disorder reduces the number of natural killer cells. Pessimism was related to
depressed mood, lower numbers of helper T-cells, and lower levels of natural killer cell
activity (Segerstrom, Taylor, Kemeny, & Fahey, 1998). Mental illnesses are prevalent
among HIV/AIDS patients (AIDS Institute, 2012). On this premise, the higher CD4
counts among non-API patients with HIV/AIDS is practically understandable, and in fact,
should be expected. However, as cited in the discussion of results for RQ1, the difference
in health outcome variables is compared directly between groups without adjusting for
confounding variables, as the historical data offered little scope to include control
variables such as demographic, health, or occupational data. Adjusting for these factors
could potentially extract precise differences between study groups in terms of health
outcome variables. The fact that historical data did not provide any scope to include
confounding variables is the major limitation of the study.
However, it is interesting to note that this result is also congruent to the common
notion of APIs. Due to aculture characterized by tight communities, APIs are likely to
view psychotherapy as “disgraceful” for themselves and their family and to consider “talk
therapy” to be “useless” (Tseng, 2004, p. 153). Therefore, APIs are less likely to seek
therapy. Individuals who do not adhere to psychotherapy are likely to struggle with a lack
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of social supports such as health education and health insurance (Fenger et al., 2011).
And API patients refuse to seek mental health care due to loss of face and negative
perceptions about mental health issues (Fenger et al., 2011). This result warrants further
exploration, because basing these assumptions on historical data limits the theorizing for
other factors. I recommend expanding on the results of this study to explore additional
factors that determine API behavior with regard to seeking mental health care.
In summary, this study offered explanation for the differences between APIs and
non-APIs with regard to their care-seeking behaviors, based on historical data. Neither
social support, as defined by Irvine et al. (2015), nor psychotherapy retention were found
to have significant differences across the groups. Moreover, the results did not show
significant differences in CD4 counts between non-API and API patients diagnosed with
HIV/AIDS. Statistical methods used to analyze the data did not include control variables
to extract precise results due to non-availability of necessary data, which proved to be a
limitation for the study. I discuss the implications of the study results in the next section.
Implications
The current study offered an initial baseline for future studies with regard to the
behaviors of APIs in comparison to non-APIs. Bandura’s (1989) SCT states that
individual behavior is learned and changed through environmental influences (McLeod,
2011), and social support is one factor that enables behavior changes. I sought to provide
evidence on the importance of social support in the behaviors of cultural groups and their
collective behaviors regarding mental health care – an important concept especially for
therapists and researchers. Culture-specific factors must be taken into consideration in
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improving and creating psychotherapy and treatments for cultural groups. For example,
Donkin et al. (2006) found that even when health education is provided to APIs, they
continue to actively search for evidence that confirms their preexisting beliefs because
the health information given to them may cause discomfort or go against their beliefs.
These researchers suggested that perceptions of illness are often based on beliefs that are
influenced by family, culture, and past experiences. Bhattacharya (2004) found that this
is especially true in Asian communities. A few studies (e.g., Hatfield et al., 1996, and
Leong et al., 2011) focused on the perception of APIs on mental health and health
concerns, which demonstrates the importance of considering and understanding the
culture of an individual when undergoing psychotherapy.
This study contributes to the body of literature on APIs and their mental healthseeking behaviors. The main research gap was a scarcity in the theorization and nuancing
of the experiences of APIs in comparison to those of non-APIs. The purpose was to
provide evidence on the relationship between social support and psychotherapy
adherence among APIs, but there is still a need for further studies to understand the
specific determinants of API behaviors with regards to mental health.
Yeun, Baek, and Kim (2013) examined SCT and health promotion behavior in
API patients who were not diagnosed with HIV/AIDS. There are also studies that
demonstrated links among social support, receptivity to mental health care,
psychotherapy attendance, and health outcomes as measured by CD4 and viral load
(Irvine et al., 2015; Yeun et al., 2013). These links could be specific characteristics of
Asian cultures that result in culture-specific attitudes and behaviors toward HIV/AIDS
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and that foster ideas about seeking and remaining in mental health care that differ from
the ideas characteristic of non-Asian cultures (Irvine et al., 2015; Yeun et al., 2013).
These findings show the need for specific attention to people who are APIs and who have
HIV/AIDS.
Previous researchers have targeted non-API populations (Irvine et al., 2015), and
some have touched on APIs and psychotherapy (Kang et al., 2006; Sue et al., 2012), but
there is a lack of research on people who are APIs and who have HIV/AIDS. It is
imperative to focus on the API population due to its potential cultural needs for an
expanded approach for using improved social support to encourage API access to mental
health assistance maintenance through their illness (Irvine et al., 2015). In this study, I
aimed to expand existing studies on social support, psychotherapy, and HIV/AIDS
patients, focusing the study specifically on the cultural background of APIs living in the
United States.
For hospitals and nursing facilities, the outcome of this study helps practitioners
to understand the experiences of APIs who have HIV/AIDS and to understand the
culture-specific factors that affect their behaviors. This study seeks to contribute to the
under-researched area of the possible relationship among social support, psychotherapy
attendance rates, and health outcomes in a vulnerable population in which the HIV/AIDS
infection rate is increasing and that may have unique sociocultural needs. Hospitals and
care facilities must take advantage of the shifting paradigms of mental health care.
Further improvement of care treatments and support systems would help to decrease
dropout rates and increase retention in mental health care. Using social relationships as a
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means to support psychotherapy retention would prove beneficial not only for hospitals,
but also for the patients themselves.
The results of the study also demonstrated the importance of record keeping as a
means of properly planning the services to be offered to patients. Meticulous data
collection was shown to be quite critical in determining the strategies to develop services
and programs that could help patients with HIV/AIDs. Funding for the population could
be obtained through sufficient data, thereby allowing researchers and practitioners to
develop appropriate and effective programs for patients.
Moreover, the results of this study provide an idea of how social support can be a
major factor in determining not only the psychotherapy retention of APIs diagnosed with
HIV/AIDS, but more importantly, in understanding how social relationships affect the
intrapersonal and interpersonal processes of those individuals. In the next section, I
discuss the limitations of the study based on the current literature on social support,
psychotherapy, and APIs.
Limitations
Despites the benefits previously mentioned, the results of the study must also be
interpreted in light of its limitations. One important factor is that the data used for this
study was purely historical. The use of historical data comes with the assumption that all
of the reports are held as truth, and that the reports capture the general conditions of the
API and non-API patients with HIV/AIDS. However, this limits the data collected for
analysis, and, consequently, limits the depth of analysis that can be done on the data. This
current study can only use ANOVA or comparisons between APIs and non-APIs. The
	
  

94	
  

lack of depth in terms of the richness of the historical data could have confounded the
results. Moreover, other research designs would not have been conceptually fit.
Although heterogeneity of sample groups is present, the study lacks
generalizability in the sense that the differences were weak or not significant. Moreover,
the use of historical data did not account for the confounding variables that were present.
To address this, a mixed method could have been used to further understand the nuances
of the experiences of APIs who have been diagnosed with HIV/AIDs.
In relation to sampling, it cannot be said that extraneous variables and confounds
were controlled, or that procedure was uniform. Thus, several random and uncontrolled
factors could possibly have affected the results of the study. In assessing the factors that
may have influenced the results, the confines of this study should also be taken into
consideration, such as the demographic characteristics of the sample population, time
constraints, and the richness of historical data collected. These confounding variables
may have affected the results of the study. Moreover, the data came from the perspective
of care personnel, and not from the perspective of the API and non-API patients. This
factor alone limited the level of analysis that could be applied to the data. Future studies
could consider the perceptions and personal experiences of APIs who have HIV/AIDS
using other methodologies that can gather more subjective and specific data such as
interviews or surveys.
Another issue relating to generalizability is the fact that the data for the study was
obtained from historical data from a single community health center. The results of the
study were only derived from the limited field of data available, and thus, cannot be
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easily applied to other contexts. Many interesting results came from the study, but
because of the weakness of the differences found, the data cannot be interpreted broadly.
For example, the lower rate of psychotherapy attendance for APIs diagnosed with
HIV/AIDS in comparison to that of non-APIs could have implications for the social
support given to API patients, but the difference, albeit insignificant, also shows a
divergence between this study and results of previous studies focusing on the
psychotherapy attendance of APIs and social cognitive theory. This could be addressed in
future studies by considering the extraneous factors and revising the research design
used.
In relation to this, another limitation included the insufficient data to draw the
relationships among different factors. Historical data were obtained to determine the
importance of social support for patients with HIV/AIDs, and while this allowed the
researcher to look into patterns based on patient information, it was insufficient for
determining whether these relationships have empirical bearing. To address this, future
researchers could employ a qualitative approach to explore the lived experiences of
patients with HIV/AIDs and to determine the impact of social support in that context.
Another study limitation was the scarcity of research involving APIs diagnosed
with HIV/AIDS. Although social support and social cognitive theory are two topics with
a rich body of literature, their application in the context of APIs diagnosed with
HIV/AIDS still lacks substantiated evidence. For one thing, it was difficult to
contextualize the results with the experiences of APIs because of the limited data from
previous research. There is minimal discussion in the literature of the relationship
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between social support and treatment adherence (including psychotherapy attendance)
among APIs. Hall et al. (2011) characterized APIs as showing a high dependence on their
families, friends, and communities for resolving issues. In contrast, Kang et al. (2006)
described the close communication within the API community, but showed that there is
pressure on Asians with HIV/AIDS to conceal their illness and to avoid medical or
psychological treatment. I recommend that future studies explore in greater detail the
ways that experiences differ among APIs, and also between APIs and other groups. It
would be advantageous to identify the social relationships and processes that occur within
the groups and between the individuals so that the discrepancies in the previous studies
could be explained.
Recommendations for Future Research
In light of the limitations presented above, I recommend the following:
1. It is important to understand the cultural parameters that affect the healthseeking behaviors of API patients. Thus, I recommend that future research
focus on cultural studies, and specifically on the factors that influences the
perceptions and behaviors of minority groups.
2. Future studies should explore the role of social support in the health careseeking behaviors of minority groups. This will help therapists and health care
practitioners provide and implement evidence-based strategies for practice.
3. Future studies could use other types of research design to address the scarcity
in the literature that focuses on the experiences of APIs and mental health.
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4. I recommend that between-group analyses be undertaken in order to have a
deeper understanding of the contextual differences between API and non-API
patients.
5. Demographics must be taken into consideration, especially in social
psychological studies that focus on social processes and relationships between
variables and in a cultural group.
6. It is important to examine the experiences of care providers so that the
perspectives of the APIs can be reconciled with the lived experiences of the
care providers.
7. It would be advantageous to learn more about the experiences of APIs who
have been diagnosed with HIV/AIDS in light of the stigma that these patients
experience from society. To address this, I recommend that future researchers
use qualitative methods to explore the lived experiences and discursive
meanings that APIs derive from their individual experiences.
8. I recommend that future researchers examine the stressors of care providers
and patients in order to improve treatment strategies and psychotherapy;
9. Future studies could explore other dimensions of social cognitive theory
within the context of APIs who have been diagnosed with HIV/AIDS.
Summary and Conclusion
The purpose of this quantitative causal comparative study was to understand the
impact of social support on psychotherapy attendance rates, as well as on health
outcomes such as CD4 and viral load, among API and non-API patients with HIV/AIDS.
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I used factorial ANOVA, descriptive analysis, and regression analysis to analyze the
historical medical data of HIV/AIDS patients of a community health center in New York
City.
Results of the study showed that patients diagnosed with HIV/AIDS do not have
higher psychotherapy attendance rates over time compared to patients not diagnosed with
HIV/AIDS, and showed that non-APIs have higher psychotherapy attendance rates over
time compared to APIs. In addition, social support, as measured by the presence of case
workers, has no significant impact on retention in psychotherapy for either API patients
or for non-API patients. Moreover, health outcomes, as measured through CD4 count,
was not significantly different across differences of race. The results showed that there
was no difference regarding the health outcomes of APIs and non-APIs with regards to
viral load. I recommend future studies using qualitative methods in order to identify more
nuanced differences in the experiences of people who are APIs and have been diagnosed
with HIV/AIDS.
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